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Abstract 
Phantom limb pain (PLP) is a common complaint among amputees and despite having been studied 
for centuries, it remains a mysterious object of debate among researcher. To date, a vast number of 
ways to treat PLP has been proposed in the literature, however none of them has proven to be 
universally effective, thus creating uncertainty on how to operate clinically. The uncertainty is largely 
attributable to the scarcity of well conducted randomized controlled trials (RCTs) to prove the efficacy 
of PLP treatments. 
Phantom Motor Execution (PME) -exertion of voluntary phantom limb movements – aims at restoring 
the control over the phantom limb and the exercise of such control has been hypothesized to reverse 
neural changes implicated in PLP. Preliminary evidence supporting this hypothesis has been provided 
by clinical investigations on upper limb amputees. The main purpose of this Licentiate thesis was to 
enable a RCT on the use of PME for the treatment of PLP in order to provide robust and unbiased 
evidence for clinical practice. However, the implementation and kick-off of this clinical investigation 
required to complete few preparatory steps. For example, most amputees and PLP patients have lower 
limb amputation, thus PME needed to be adapted and validated for this population. Further, the RCT 
protocol needed to be carefully planned and made openly accessible, as per guidelines for conducting 
and publishing clinical RCT. Finally, a secondary aim of this thesis emerged with the need of providing 
long term relief from PLP to patient. Preliminary evidence seemed to indicate that in order to maintain 
pain relief, periodic rehearsal of the phantom motor skills acquired through PME is necessary. This 
raised the question of whether it is beneficial and possible to translate the technology from clinic to 
home use, question that was explored employing both quantitative and qualitative methods from 
engineering, medical anthropology, and user interface design. 
The work conducted within this thesis resulted in the extension of PME to lower limb patients by 
proposal and validation of a new and more user-friendly recording configuration to record EMG signals. 
The use of PME was then shown to be efficacious in relieving PLP with a case study on a patient. The 
protocol for the RCT was then designed and published. These two first steps permitted the 
establishment of the RCT, which is currently ongoing and expected to close in March 2021. With regard 
to the secondary aim of this thesis, the work conducted enabled PME to be used by the patients in the 
comfort of their home, while it also allowed investigate the benefits and challenges generally faced 
(not only by PME) in the transition from the clinic to home and its effects on treatment adherence. The 
work conducted is presented in the three appended publications. 
Future work includes the presentation of the results of the RCT. Further, having a way to modulate PLP 
is an incredibly useful tool to study the neural basis of PLP. By capitalizing on this tool, we are currently 
conducting brain imaging studies using fMRI and electroencephalography that are the main focus of 
the work that lies ahead. 
Keywords: Phantom Limb Pain, Phantom Limb Sensations, Phantom Motor Execution, Amputation, 
Randomized Controlled Clinical Trial. 
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CHAPTER 1 
 
CHAPTER 1. Introduction 
 
 
Motivation 
Phantom limb pain (PLP) ― “painful sensations referred to the lost body part”[1] ― is a common 
complaint among amputees, with different sources attesting its prevalence between 50% and 88% [2]. 
As other chronic neuropathic pain conditions, PLP has negative effects on a person’s well-being. For 
example, amputees with PLP are less likely to wear a prosthesis thus resulting in additional disability 
[3]. Moreover, most amputees report PLP to affect their sleep and episodes can be so intense to wake 
the sufferers through the night [4]. This causes the sufferer to be sleep deprived, condition which has 
been shown to reduce pain tolerance [5]. PLP can also have social implications. For examples, it has 
been shown that PLP decrease employment and satisfaction with working life [6]. Despite being a 
known condition since a long time, first appearing in the literature in 1551 [7], PLP is still poorly 
understood. Signs of this lack of understanding are for instance the fact that despite the large number 
of treatments described in the literature, none of them has proven to be decisively effective and 
guidelines for treating patients are currently absent [8]. This can be largely attributed to the scarcity 
of Randomized Controlled Trials (RCTs) on such treatments, which additionally tend to be of poor 
quality [9]. More recently, restoration of the control over the phantom limb and the exercise of such 
control have been hypothesized to reverse neural changes implicated in PLP [10]–[12] and preliminary 
evidence in support of this hypothesis has been provided by clinical investigations on upper limb 
amputees [13], [14]. The approach to enable phantom motor execution (PME) is based on the use of 
a myoelectric pattern recognition (MPR) system that allows to decode motor volition while providing 
real-time feedback via virtual and augmented reality (VR-AR). Exercising PME is hypothesized to 
reengage the motor neural circuitry in the central and peripheral nervous systems, ultimately resulting 
in PLP reduction. However, the evidence in support of PME as an effective way to treat PLP was 
obtained only on upper limb amputees at first. Further these clinical investigations were not conducted 
as RCTs. Hence, they did not ensure that the effects on pain relief reported were not due to any factor 
other than the active treatment component (i.e. PME).  
When considering how the reduction of PLP relates to acquisition and maintenance of motor skills of 
the phantom limb, it becomes clear that PME is not a cure for PLP which can be taken at one instance 
and solve the problem forever. The preliminary evidence available seems to indicate that in order to 
maintain pain relief, periodic rehearsal of the phantom motor skills acquired through PME is necessary. 
PME should therefore be regarded as a habitual practice to maintain skilled control over the phantom 
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limb. The question as to whether this treatment approach could be self-administered at home and 
what would be required in order to ensure treatment quality and adherence then emerges naturally.  
Finally, having access to a proved method of relieving patients from PLP would not only be important 
for improving the life of those suffering from it, but it would also be very useful to increase our 
understanding of the neural basis of this curious phenomenon. For example, an efficacious treatment 
would allow to modulate PLP and to study the neural correlates of such modulation. Phantom 
sensations (painful and non) are a peculiar phenomenon that raises a host of challenging questions 
relevant to philosophy, psychology, and neuroscience. The following quotation of. Joel Katz during an 
interview with Cassandra Crawford [15], clearly summarizes what researchers find fascinating in the 
experience of phantom limbs- 
“I think that whoever solves the puzzle or problem of the phantom limb will also solve the problem of 
perception . . .That is what I like so much about the phantom: I think of it as a window into the central 
nervous system”  
Katz 2005 
Scope 
 This licentiate thesis is focused on the following tasks:  
1. Technologically enabling PME by use of MPR and VR/AR in lower limb amputation (Paper A). 
2. Providing evidence that PME is a viable option for PLP relief in lower limb amputees (Paper 
A). 
3. Design a large-scale, international RCT in order to gather unbiased and stronger evidence of 
PME as a valid treatment for PLP (Paper B). 
4. Enabling patients to use PME aided by MPR and VR/AR at home and monitor the progression 
of their PLP (Paper C). 
Thesis outline 
This thesis is divided in two parts. Part I is constituted by eight introductory chapters, including the 
present one, that intend to give an overview of the research field and the reasons that motivated this 
work. Chapter 2 describes the historical context, the major contributors to the field and the prevailing 
neuroscientific theories that have provided the boundaries for what phantom limbs can be or can do 
from a theoretical perspective. Chapter 3 describes the experience of phantom phenomena from a 
phenomenological perspective. Chapter 4 seeks to give a neurological explanation of phantom limb 
sensations (PLS) and PLP giving an overview of the central and peripheral mechanisms involved. 
Chapter 5 lays out an overview on the prevailing theories of PLP and PLS. Chapter 6 gives an overview 
of the currently available treatments, giving special attention to PME. Chapter 6 provides a summary 
of the contributions of the included papers. Finally, Chapter 7 outlines of the work ahead. Part II 
contains the appended publications of this thesis. 
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CHAPTER 2 
 
CHAPTER 2. Historical Context 
 
 
Amputation is one of the most serious surgical interventions and the thought that early 
societies, which we often call “primitive”, were able to perform it successfully is fascinating. 
We find evidence of this in 27,000-years old cave paintings showing the imprint of hands with 
missing phalanges (Figure 1) [16], or in the oldest successful trans-humeral amputation found 
in a Neolithic site (4900-4700 BC) in France [17]. Moreover, survival after amputation is also 
well documented throughout history as abundant archeologic findings of prosthetics devices 
can confirm [18], [19]. Yet, perhaps even more fascinating is the total absence of phantom 
limbs from medical records until the 16th century: quoting Prince and Twombly “there is every 
reason to suppose, and no reason to doubt, that individuals with an amputation have, in all 
times, experienced phantom sensations of some kind . . .”[20]. These observations rise the 
question of why certain phenomena are 
reported in medical literature while 
others remain unnoticed. For instance, 
one could legitimately wonder how come 
migraine was already known by the 
Ancient Egyptians (2500 BC) [21], 
whereas phantom pain was never 
mentioned before 1551, the year when 
Paré (1510–1590) made the first 
documented reference [22]. Following 
up on this thought, one could also be 
intrigued by the fact that, starting from 
that first report onwards, phantom limbs 
became a topic of high scientific interest 
to the point that the literature available 
today has past reached forbidding 
proportions.  
One interpretation is to regard this as an example of how the scientific and medical 
community may not be open to investigation of a sensorial phenomenon, unless it can be 
integrated in the body of theories of the time. This implies that the very first accounts might 
have provided a paranormal interpretation of the perceptual experience instead of a scientific 
 
Figure 1: Negative hands. Impressions of hands made by 
stencil technique from the Upper Paleolithic period 
(about 27,000 years old). The paintings are found in the 
Caves of Gargas in the Pyrenees region of France. 
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one. For example, while examining medieval folklore accounts describing the loss and 
miraculous restoration of body parts, Price and Twombly [20] came across what they judged 
to be clear metaphorical allusions to phantom limb phenomena, thus pushing back the 
recorded history of phantom limbs to the tenth century. In his historical account of the process 
that brought phantom limbs from being a miraculous phenomenon to an instrument for 
investigating neural plasticity and consciousness, Wade [23] ascribes these early folkloristic 
descriptions to the first phase of the process. It is only in later phases that descriptions are 
furnished with theoretical speculations. Noteworthy is Finger and Hustwit’s work [24] where 
they addressed the history of phantom limbs by reviewing the contributions made to the 
medical literature before the 20th century, thus giving an insight of how many people from a 
variety of different back-grounds were writing on the topic, each with different motives in 
mind.  
Paré (1510) provided the first of report of 
phantom limbs to the medical field. He was a 
French military surgeon that made considerable 
progresses in the surgical amputation technique in 
a time when the most common cause for this 
intervention was gangrene [23]. As a result of his 
improved technique, patients were now more 
likely to survive, which led him to work more 
closely with amputees. For instance, he designed 
several ingenious prostheses with movable parts 
(Figure 2). Through his work with amputees, he 
also discovered that they tended to have 
sensations in their lost limbs. In line with his 
primary purpose of improving the surgical 
procedure for amputation, he eventually wrote a 
commentary warning to other surgeons of the 
existence of deceptive sensations (phantom 
sensations) in dead tissue which may dissuade 
from performing a lifesaving amputation required 
to stop the gangrene from spreading [24].  
By ascribing the phantom feelings to the 
stimulation of the severed stump nerves, Paré’s initial accounts were integrated with the 
prevailing theory of perception of his time [25]. In contrast, just few decades later, Descartes 
decided to take his theoretical speculations beyond the commonplace knowledge of his time 
and exploited the phenomenon to corroborate his dualistic philosophy of body and mind, 
specifically as a proof of the fragmented and unreliable nature of the senses and as a further 
evidence of the unity of the mind. These two first reports remained rather isolated until the 
nineteenth century when also other scientists incorporated phantom limbs into their work. 
Reasonably this incorporation process was catalyzed by the establishment of basic 
neuroscientific concepts such as the existence of nerve cells and animal electricity [26], the 
law of specific nerve energies (Muller [27]), the idea of pain as an independent tactile quality 
 
Figure 2: Artificial leg. Leg designed by 
Ambroise Paré (1575) available in the 
collection of Images from the History of 
Medicine, which is a library of the U.S. 
government's National Institutes of Health, 
Public Domain. 
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(Frey [27]), or the existence of a sixth sense associated with the muscles (Bell [28]). Further, it 
was during this period that Silas Weir Mitchell (1829–1914) [29], one of the founders of 
neurology in the United States, coined the name “phantom limb” unequivocally introducing 
the concept in the scientific discourse.  
Throughout the nineteenth century most views on the mechanisms underlying phantom 
sensations converged on the general idea that activity in the severed nerves alone could 
account for the manifestation of phantoms [30]. However, with the turn of the twentieth 
century and the rise of neurology, the peripheral theory started to be challenged by a 
dichotomous central interpretation, in which the central nervous system came to assume the 
primary role. Precisely, this view can be traced back to the early 1900s when Head and Holmes 
(1911) coined the concept of “body schema” to describe the spatial model of the body that 
the brain constructs based on sensory inputs. Building on this, Pick (1915) proposed that 
phantom phenomena are perceptual manifestations of the persistence of the lost limb in the 
body schema [31]. In accordance with this view, he also remarked that children with 
congenital absence of limbs, or after amputation in the first years of life, do not have phantom 
limbs due to the lack of afference required to build the body schema. 
Two decades after Head and Holmes, Schilder (1935) began what Crawford renamed as the 
psychologization of the body schema. Namely, he deemed that the emotional processes are 
necessary in order to guide the sensations and perceptions that form the body schema [15]. 
Within this framework, the phantom represented “a reactivation of a given perceptive pattern 
by emotional forces” [32]. This view, combined with the concept of denial in psychology, 
popularized by Anna Freud, eventually led to psychogenic explanations of phantom pain such 
as the view of pain as the narcissistic inability to renounce the integrity of the body and adapt 
to the defect [15][33]. In clinical practice, psychogenic explanations tended to convene to the 
conclusion that phantom pain is the interpretation of phantom sensations by individuals who 
show psychopathology [34].  
The notion of phantom limbs as expression of psychological trouble remained unchallenged 
till post second world war, however further advances in neurology created favorable 
conditions for a shift. In particular, the cortical homunculus (Figure 3), discovered by Wilder 
Penfield and colleagues in 1937 [35], is the key concept that allowed phantom limbs to take 
official residence in the cerebral cortex of amputees. Early references to Penfield’s 
homunculus were in line with the body schema theory and regarded the somatic and motor 
cortical maps as the physical manifestation of it. Subsequently the homunculus was used to 
account for the morphology and certain phenomenological peculiarities of phantom limbs. 
For example, it was used to explain why sensations in extremities, such as phantom hands or 
feet, tended to be more vivid than those arising from other parts. Namely, most vivid phantom 
sensations were said to be perceived in those body areas with the largest cortical 
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representations. Similarly, telescoping -the 
perception of a shortening phantom- and the 
fading out of parts such as forearms and shins 
of the phantom was seen as a consequent of 
the fact that those portion of the phantom 
were less vivid to start with [36]. In this light, 
the fact that phantom experiences in people 
with congenital limb absence were not 
reported until 1961 [37] does not surprise. As 
already mentioned, phantom sensations in 
congenital limb absence were irreconcilable 
with the early body schema theories. Indeed, 
congenital sensations were explicable only by 
admitting that the body schema was at least 
partly built in the central nervous system. 
Melzack later commented that previous 
reports of phantom experience in congenital 
amputees were probably rejected due to the 
lack of conceptual framework to make sense of 
these accounts [38]. 
Although the idea of an innate neurophysiological structure of the phantom was first provided 
by Penfield’s work in 1937 it was not until the 1990s, also thanks to extensive foundation work 
conducted during the 1980s on monkeys [39]–[45], that the homunculus was used to provide 
empirical evidence of the properties of these maps in relation to phantom sensations. The 
microelectrode mapping done on monkeys investigated the effect of deafferentation and 
amputation on cortical sensorimotor maps and came to challenge the idea that the adult brain 
is hardwired with stable neuronal connections.  
By the mid-90s, thanks to the advance of medical imaging technologies, it became possible to 
examine whether adult plasticity takes place also in humans and to further study the 
perceptual correlates of such plasticity, which could not be done in animals. This led to 
phantom phenomena being attributed to plastic changes in the cortex taking place after 
amputation. For example, cases of phantom referred sensations prompted by far-removed 
trigger points, previously unexplainable by peripheral theories and by fixed neural 
connections, started to be documented only now. This type of sensations is also known as 
“dual percept” because it is perceived as if it were applied simultaneously at the actual 
stimulation point and at a location on the missing limb [46]. Perhaps the most known report 
of this dual percept phenomenon comes from Ramachandran and others [47]–[50] 
demonstrating that referred sensations are evoked in phantom limbs by stimulating 
topographically organized hand maps in the lower face and stump.  They explained the referral 
of sensations as a result of cortical plasticity where face and stump representations invade 
the deafferented area, as corroborated by the layout of Penfield’s homunculus were the hand 
area is flanked by the face representation on one side and the wrist’s on the other. They 
further suggested that this remapping could explain the very existence of phantom limbs: 
 
Figure 3: The motor homunculus. Sketch by 
Penfield, probably 1951. ©Osler Library of the 
History of Medicine.  
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spurious discharges from neurons innervating the trigger zones could be interpreted as 
originating from the missing limb. It was later pointed out that this phenomenon is actually 
exceptionally rare (present in <7% of the cases) [51] and therefore could not explain the 
presence of phantom phenomena, which are virtually universal in amputees. Moreover, it has 
been shown that the topography of referred sensation is rather dynamic over time while the 
invasion into the deafferented cortical zones was said to be a very robust phenomenon [52]. 
Throughout the last two decades the discourse has mostly focused on determining the nature 
of the cortical reorganization taking place after deafferentation and its implications for 
phantom phenomena. Elbert and Rockstroh (2004) outlined the range of reorganizational 
changes taking place in the human representational cortex and identified three distinct 
modalities. Namely “experience- or use-dependent” plasticity, enhanced by behaviorally 
relevant afferent activity; “injury-related” reorganization, driven by loss of input as in the case 
of amputation or blindness, and “maladaptive” plasticity, as in the case of focal hand dystonia 
that causes involuntary movement or cramps and is triggered by intensive training of a 
particular movement [53]. In the recent years, these plasticity models have been used and 
disputed by different research groups to explain the etiology of PLP. On one side a 
maladaptive plasticity interpretation sees PLP as the perceptual correlate of maladaptive 
reorganization [54], on the other side an experience-dependent plasticity interpretation 
regards phantom pain as the driving force that preserves the representation of the missing 
limb [55]. Non-painful phantom sensations have been investigated to a lesser extent also 
owing to the difficulty of reliably evoking these sensations, however it has been shown that 
phantoms sensations are not related to cortical reorganization [51], [56]. Another undeniable 
source of cortical change is the use-dependent plasticity resulting from the use of a prosthesis 
or the adaptive compensatory use of other body parts [57], [58]. These effects should also be 
taken into account when looking for a neural correlate of phantom phenomena. The debate 
is far from being settled, leaving open the question of how of phantom limbs and phantom 
pain originate and become chronic. Phantom limbs have a special place in neuroscience: not 
only can they serve as markers for tracking neural plasticity in the adult brain, but they can 
also provide fundamental insights into the processes underlying bodily awareness and 
consciousness. 
The purpose of this chapter was to give an historical context to the biography of phantom 
limbs and pain. This should provide a sense of how tightly linked the etiology and 
manifestation of phantoms limbs are to what is considered legitimate by the current 
theoretical framework. As we have seen, the context seems to set the limits of what is possible 
for phantom limbs to be, feel and do. The following chapter is dedicated to the 
phenomenology of phantom limbs, however in the light of what has just been pointed out, I 
encourage to read what follows keeping in mind that although the literature has exploded in 
size, and the characteristics of phantom limbs have already been investigated far and wide, 
the story we are telling probably remains incomplete. 
“Normal science does not aim at novelties of fact or theory and, when successful, finds 
none” 
Thomas Kuhn 
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CHAPTER 3 
 
CHAPTER 3. Phenomenology of phantom limbs 
 
 
The purpose of this chapter is to provide a description of the experience of phantom 
phenomena. It must be noted that this is an incredibly challenging task since the study of 
phantom limbs is tightly linked to the study of the content of conscious experience, such as 
perceptions, feelings and emotions, which is subjective. The difficulty of establishing an 
objective description is reflected in the contradictory accounts found throughout the 
literature which are largely based on short-term studies with small groups or exceptional 
cases. This chapter is concerned with the phenomenology of phantom limbs, which focuses 
on determining the essential properties of this experience rather than giving a psychological 
or neurological description.  
A common and natural consequence of amputation is the perception of phantom phenomena: 
the perception of sensations located in a missing limb [59]. Phantoms have also been reported 
occurring following mastectomy [60], [61], amputation of genitals [62], rectum [63], and 
removal of other body parts such as eyes [64], bladder [65], uterus [66], tongues [67], or teeth 
[68]. Moreover, phantom phenomena are also associated with conditions other than 
amputation. This is the case for supernumerary phantom limbs occurring following nerve 
avulsion [69], spinal cord injury [70], stroke [71], head injurie [72], anesthetic nerve block [73]. 
Further, it has been found that phantom limbs were experienced also by about 20% of children 
with congenital limb absence [37], [38].  
Phantoms limb can be perceived with the vividness of a real limb. For example, it has long 
been documented how amputees may forget the loss of the limb and reflexively attempt to 
step out of bed, answer the phone, rub an eye, or shake hands with the missing limb [74]. The 
remarkable reality of phantom limbs owes to the wide range of sensations experienced, which 
can be non-painful or painful. Another common consequence of amputation is the perception 
of pain in the residual limb, which is called stump pain or residual limb pain (RLP). Non-painful 
phantom sensations do not pose a clinical problem for the amputee however they often 
coexist with RLS and phantom pain and oftentimes influence each other [75], resulting in 
additional difficulty to separate these elements for appropriate treatment.  
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 In order to disambiguate the descriptions of phantom 
phenomena, Danke [76] introduced a taxonomy, later 
popularized by Nikolajsen and Jensen [2] as the “phantom 
complex”. Components of the phantom complex are 
phantom limb pain (PLP) - painful sensations referred to the 
absent limb; phantom limb sensation (PLS) - any sensation 
in the absent limb, except pain; and stump or residual limb 
pain (RLP) - pain localized in the stump. However, more 
recently it has emerged that this definition is problematic 
as it is based on the perceived location of the pain and it 
fails to acknowledge the multiple etiologies behind RLP, 
such as neuroma, complex regional pain syndrome, and 
nociceptive pathology [77], [78]. The main problem with 
grouping different pathophysiological mechanisms under 
the common label of RLP is the risk of not recognizing that 
neuroma pain (NP) can manifest itself as pain in the missing 
limb [79], [80], and thus be classified as PLP without actually 
being such. Another problem relative to the categorization 
of postamputation pain based on the perceived location, is 
the fact that phantoms limbs are sometimes perceived 
within the residual limb (Figure 4) [81]–[83]. In order to 
correctly classify the pain, which is essential for proper 
treatment, it is therefore necessary to consider the 
pathophysiology of the pain reported by the patient. The 
purpose of the rest of this chapter is to describe the 
phenomenology of phantom sensations and phantom pain. 
A general description of the various types of RLP together 
with a more detailed description of their pathophysiology is 
given in Chapter 4. 
Phantom sensations 
The prevalence (not to be confused with incidence) of non-painful sensations has been 
reported in 70% to virtually all acquired amputees [48], [84]–[88]. Importantly, Hunter et al. 
recognized that phantom limb awareness, the general awareness of the existence of the 
missing body part, is a distinct trait of phantom limbs which is qualitatively different from the 
experience of specific nonpainful somatic sensations [46]. Weinstein recognized three types 
of PLS, namely  exteroceptive, kinesthetic and kinetic sensations [89].  
Exteroceptive sensations include a wide range of sensory aspects, such as tingling, itching, 
pressure, warmth, or cold [46], and super-added phantom features, such as the sensation of 
wearing a shoe, a watch, or a glove [90].  
Phantom limbs are inherently endowed with proprioception and corporal awareness 
(kinaesthetic sensations): they are perceived to occupy a plausible body space, usually aligning 
with the stump and moving with it [91], and are perceived to be of a particular size, shape and 
 
Figure 4: Telescoping. Patient with 
phantom retracted into her stump. 
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posture [92]. For example, phantoms may feel perfectly normal in all respects, retaining a 
shape and form of the former limbs [86], [93], however with time they may also fade away 
leaving the phantom with missing parts [69]. In some cases phantom limbs can be in an 
habitual and normal position, conversely they might also occupy an abnormal position which 
can be constantly fixed or anatomically impossible [87][48]. Phantom can be weightless or be 
perceived as heavier than normal limbs [86], and often they are reported to shrink in size or 
shorten in length in a process first described by Guéniot in 1861 [96] and known as 
telescoping. Nevertheless, telescoped phantoms can also grow back and return to their full 
length, for instance when wearing a prosthesis (Figure 5) [95]. Likewise, they can actively 
telescope back when doffing the prosthesis [87]. Amputees tend to perceive predominantly 
the distal parts of the limb, although perception of exclusively proximal portions is also 
possible [87].The perception of distal parts of the phantom, in combination with the dropping 
out of the proximal parts leads to the perception of the phantom as detached from the 
residual limb, floating in air (Figure 6) [70].  
Finally, amputees can perceive kinetic sensations, of voluntary or involuntary movements 
[97]. Ramachandran and Altschuler [98] reported that many patients can voluntarily move 
their phantoms, but they also reported an equal number of amputees that claimed that their 
phantom is immobile, assimilating this kind of paralysis to the “learned paralysis” that 
commonly affects stroke patients. Controllable phantoms have been described as 
intentionally exploitable, as illustrated by Poeck (1964) with the example of an 11-year old girl 
with bilateral peromelia who learned to solve simple arithmetic problems by counting on her 
phantom fingers [99]. Another famous example is provided by pianist Paul Wittgenstein, 
whose right arm was amputated during WWII. After the war he learned to play the piano with 
his left hand resuming his concert pianist career. It is believed that the movements of his 
phantom hand played a crucial role in the acquisition of his unusual left-handed dexterity, as 
he allegedly used the phantom hand to choose how to use the fingers for pressing the piano 
keys [100]. Spontaneous movements are instead exemplified by Fairley’s patient who 
remarked, “When I play tennis, my phantom will do what it’s supposed to do… It will give me 
balance in hard shots”. Involuntary and automatic phantom movements have been described 
as jerking, jolting, spasm or tremor movements [101]. An example of these is provided by 
McGrath and Hiller’s patient who experienced an unusual sensation referred to as nerves 
jumping, which was described as a “weird tingling that starts in your toes and goes up to your 
stump and the nerves jump. The stump jumps up and down (1 or 2 inches) for a few 
seconds.”[102]. 
It has also been reported that phantom limbs interact with the surrounding world and have 
different adaptation strategies. The most exhaustive study in this regard was authored by 
Jalavisto [103]. In this study, 173 subjects were asked to give an accurate account of what 
happens to their phantom when they are placed near a wall or table and had to move the 
stump so that the phantom, if unchanged, would occupy some place within the wall or the 
table. Two main strategies for phantom-object interaction emerged, namely an adaptive 
strategy, in which the phantom disappears, shuns the obstacle or moves, and a fixed strategy 
in which the phantoms do not adapt and penetrate objects instead. Interestingly, it was found  
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Figure 5: After Image GN2.  
(Caption and photo reprinted with permission from Wright, Alexa. 1997. After Image. London, England: 
www.alexawright.com.) 
 
GN 
Date of amputation: 1964 
Time since amputation: 33 years  
Age: 52 Male 
Motor cycle accident: brachial plexus lesion 
Arm amputated 4 months after accident 
No previous damage to limb 
 
“At first I had a phantom limb whilst the arm was still there, because the arm was paralyzed. The phantom used to float 
away from where the arm was. I was in a hospital bed and it would float through the bedclothes and get cold, so I 
developed this habit of sleeping on my right side so the phantom limb drifted into the mattress and stayed warm. At the 
beginning used to believe I could get the arm back. 
Now nearly all of the arm has disappeared, but if I am wearing the artificial arm and I swing my arms as I walk, the right 
arm swings. If I can see the artificial hand out of the corner of my eye or I can feel it up against my leg the phantom 
hand is inside the glove. If I can't see the artificial hand, I can be wrong; I could be six inches out as to the location of the 
hand: the phantom hand can miss the artificial one in terms of spatial placing.  
There is an intermittent crushing pain, but the phantom is always there. It’s part of me; it will never go away completely. 
I will always be this; I will always have two arms, it’s just that one of them is missing. The real me is without the 
prosthesis; its uncomfortable; it’s not me. It is surprising how one armed I look when I see photographs of myself; my 
self-image is two armed.” 
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Figure 6: After Image RD2  
(Caption and photo reprinted with permission from Wright, Alexa. 1997. After Image. London, England: 
www.alexawright.com.) 
 
Date of amputation: October 1995 
Time post amputation: 21 months  
Age 71: Male  
Road accident in which arm was crushed 
No previous damage to arm 
 
“As our car bowled over in collision with another car, my arm went out of the window and was crushed. X-rays later 
revealed that the arm was severely damaged, but the hand was left intact.  
The phantom is continuous; it takes the form of my hand. It is sometimes painful and sometimes just sensation. I feel I 
can control the movements of the hand until I suddenly realize that it isn't there. The hand is slightly clenched fist, and 
that doesn't really change; it can only go about three quarters unclenched. The pain is mostly in the third finger; that 
sometimes hurts and is painful as though I had broken it. The hand is the same size as my real hand, but much heavier. 
It itches a lot of the time and I want to scratch it. 
I can kid myself that I can make the phantom limb move. It’s really just a sort of opening & closing: the hand moves from 
the wrist downwards, but rotation of the wrist isn't available. I have only got finger and hand joint movements. When I 
haven't moved it for a while it becomes stiff. 
I can't imagine being without the phantom because it is there all the time and it is very much like eating or breathing: I 
can put up with it quite adequately and would probably miss it if it went away. I might wish it wasn't so irritating, but I 
think I would rather keep it as it is than risk losing it.” 
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that that amputees younger than twenty-five were more likely to described their phantoms 
as disappearing or moving when approaching the obstacle (adaptive phantoms), while 
amputees over age twenty-five tended to describe their phantoms as passing into the wall 
(fixed phantoms) [103]. 
The temporal characteristics of phantom limbs are remarkably variable. Among the people 
experiencing PLS, the vast majority reports of being aware of PLS within the first week post 
amputation, while the reminder perceives them within the first few weeks [86][88]. Some 
patients experience the missing limb for only a few days or weeks, while others, an estimated 
30%, continue to experience it for decades [104]. Finally, the PLS can be spontaneous 
(independent from any kind of stimulus) or they can be stimulus-dependent (i.e. evoked) by a 
discrete event or condition [105], [106]. 
Giummarra et al. [87] points out that one of the limitations of the literature of PLS is the 
anecdotal or incomplete nature of the descriptions that only explore isolated features of the 
phantom or are based on small sample sizes and extraordinary cases. To overcome this 
shortfall they ran a systematic phenomenological study on 283 amputees reporting the 
prevalence of for each of the various features of PLS, together with related protective and/or 
risk factors emerged from the analysis. Table 1 reports a summary of the number of 
participants who perceived a specific PLS. The authors found that telescoping was more 
common among upper limb amputees and amputees with more proximal amputations (both 
upper and lower limbs). Telescoping was instead less common among amputees who 
underwent vascular or diabetic amputation. The size of the phantom was not influenced by 
amputation level; however, the size is perceived more clearly when pain was also present. 
Participants reporting anatomically impossible postures were more likely to be traumatic 
amputees, while normal posture was more common in those patients with some form of 
functional impairment prior amputation. More proximal amputation resulted in phantoms 
with more varied positions. No differences in exteroception and proprioception of phantom 
limb was found considering cause of limb loss, functional impairment prior to amputation, 
infection or gangrene prior to amputation. Upper limbs were however more likely to report 
temperature in their phantom limbs. Finally, prosthesis embodiment was more frequent in 
amputees with an extended phantom compared to a telescoped phantom [87]. 
Phantom limb pain 
PLP has been long described in the literature however the many accounts are often 
inconsistent and contradict each other, leaving the newcomer to the field amidst confusion. 
The contradiction starts when trying to determine the mere prevalence of the condition. Early 
reports were more contradictory, with some indicating very low prevalence rates of PLP (1-
5%) [33], [34], [36], [107] and others as high as 50% [91]. Recent reports are more 
homogeneous reporting rates between 60% and 80%  [15], [108],[109]. Table 2 is taken from 
Crawford’s book “Phantom limb: Amputation, embodiment, and prosthetic technology” 
(2015) [15] and shows how the prevalence of PLP has steadily increased over the years up 
until the 90s, then reducing slightly with the turn of the twenty-first century. The large 
discrepancies and low  
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Table 1 :Prevalence of Phantom Limb Sensations. Summary of the results of the survey conducted by Giummarra et 
al. [87]. The table reports the number (per cent) of participants of the study who perceived a phantom limb with various 
sensation. 
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rates in early reports have been attributed 
to the confusion of terminology (RLP,PLP 
and PLS) and poor sample selection 
presumably taken from patients requesting 
for a treatment, which tended to be few 
due to the social stigma attached to the 
condition [110]. Factors including age, 
gender, side, level and cause of amputation 
do not seem to have an influence on the 
prevalence of PLP [1], [75] although a 
prospective study on 85 amputees showed 
that female upper limb amputees are 
associated with higher risk of PLP [111]. A 
clear predisposing factor related to PLP 
seem to be the presence of RLP [110]. Early 
literature excluded the presence of 
phantom limbs and PLP in young children 
and congenital amputees [36], however it has been later found by others that to a small 
extent, they occur even in this patient group [38]. Older children and adolescents have been 
found to suffer from PLP as much as adults [112]. 
There is great uncertainty regarding the onset and duration of PLP. Most often it starts 
immediately after amputation; however, some authors have reported late onset. For example 
Rajbhandari et al. [113] who described a case of PLP starting forty-four years after amputation. 
Late onset can happen in presence of a precipitating factor such as injury to the stump, or 
development of pathology to the nerves [15]. The long-term time course of PLP is also rather 
unclear. Whereas some  studies  report decrease over time in PLP intensity and frequency 
[114]–[116], others report higher likelihood of PLP when longer time since amputation has 
passed [84]. Our group has worked with patients reporting constant or increased intensity 
levels of PLP up to 48 years post amputation [13], [117]. In a prospective study on 526 
veterans, PLP disappeared over time in 16% of the subjects, decreased significantly in 37%, 
remained similar in 44%, and increased in 3% [118]. The frequency of PLP is also extremely 
variable having constant pain on one end of the spectrum to sporadic short-lasting painful 
shocks [82]. The pain is usually perceived in the distal part of the phantom. For upper limb 
amputees this means the palm of the hand and fingers, whereas for lower limb amputees it is 
the toes, foot, or ankle [94], [115], [116].  
 
The introduction of the McGill Pain Questionnaire (MPQ) by Melzack [119] has played an 
important role in standardizing the language of qualitative descriptors of PLP. Figure 7 reports 
the pain descriptors used in the classic version of the MPQ. The most common descriptors 
applied to PLP are burning, stabbing, throbbing, cramping, numb, smarting, stinging, 
throbbing, piercing, and tearing [59], [120]. However, Crawford pointed out that before the 
advent of MPQ it was common to find more vivid and colorful descriptions. For example the 
wrinkled, raw flesh, red-hot needles, wet, slimy, swollen, glowing, dry, and furry qualities of 
Table 2: Prevalence of Phantom Limb Pain. Prevalence 
over time. This table is an adapted version of the one 
appearing at page 81 in [15]. 
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phantoms, were largely documented prior to 1975, the year when the MPQ was 
institutionalized [15], [107]. Accounts of PLP with a more detailed narrative were also more 
frequent in the past. An example is the one provided by Russell (1949) reporting a sensations 
of “reopening of the old wound of his foot, followed by a sensation of blood welling up 
between his toes” [121]. 
Oftentimes patients report that the pain resembles pre-amputation pain both in quality and 
location. Katz and Melzack [122] coined the term ”somatosensory pain memories” in 1990 to 
indicate painful sensation in the phantom which resemble somatosensory events experienced 
in the limb before amputation. They interviewed 68 amputees and a total of 57% of those 
who reported having had pain before the amputation claimed that their PLP was indeed 
similar in quality and location. Nikolajsen et al. [116] asked patients to describe their pain 
before and after amputation and although 44% of patients claimed that their PLP was similar 
to the pre-amputation pain, the character of PLP was only similar to actual pre-amputation 
pain in a minority of patients[116]. Some studies found that PLP was significantly more 
frequent in the first months post amputation but not after two years in patients who suffered 
from PLP compared with those who did not [115], [116]. Therefore, although pre-amputation 
pain seems to play a role in the short-term development of PLP, it is not the only mechanism 
involved and in the long term the correlation between pre-amputation pain and PLP is not 
evident. 
It has been reported that painful experiences in the phantom limb can be modified or 
triggered by spontaneous events, autonomic reflexes (e.g. micturition), physical (e.g. weather 
changes), psychological or emotional  factors [123]. Giummarra et al. [74] explored triggers of 
phantom phenomena by surveying 264 upper and lower limb amputees with phantom 
sensations. The results showed for example that upper limb amputees were more likely to 
experience weather-induced phantom phenomena than lower limb amputees; traumatic 
amputees were more likely to report emotional triggers. The correlation between stump pain 
and phantom pains and phantom painless sensations has been evidenced by different authors 
[85], [124], [125].  Finally, it has been reported of cases of referred phantom pain in which 
pain in a phantom arm was associated with myocardial ischemia [126].  
To summarize, the purpose of the current chapter was to describe the main features of the 
experience of phantom phenomena, which can be divided in painful and non-painful phantom 
sensations. What emerges from this account is that the literature is characterized by 
contradiction and uncertainty. A possible reason for the contrasting accounts is that PLP is not 
a single syndrome but a class of syndromes with distinct etiologies, that often share a 
diagnosis based only on the perceived location of pain. 
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Figure 7: The McGill Pain Questionnaire. Reproduction of the McGill Pain questionnaire introduced by Melzack 
in 1975, reprinted from [119].  
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CHAPTER 4 
 
CHAPTER 4. Perception and motor control of phantom limbs 
 
 
The neurological mechanisms underlying phantom phenomena are not completely 
understood. In the case of amputation, phantom limbs occur when parts of the peripheral 
nervous system (PNS) are disconnected from the central nervous system (CNS), causing 
changes at every level of the nervous system. The purpose of this chapter is to present what 
is known about perception and motor control of painful and non-painful phantom limbs. 
However, in order to understand what mechanisms are involved in an abnormal condition 
such as amputation, this chapter will first provide an overview of basic and well known facts 
about the normal functioning of the sensorimotor system, which refer to Purves’ 
Neuroscience textbook [127].  
Perception 
Cutaneous sensation, proprioception and nociception 
The somatosensory system provides our brain with information coming from the external 
world as well as from our own body. This is made possible by the presence of receptors located 
all over the body, from the surface of our skin to the depth of our internal organs. 
Somatosensation comprises three different systems: the cutaneous sensory system that 
senses stimuli applied to the skin; the interoceptive system that provides general information 
about internal body conditions; and the proprioceptive system that senses the position of 
body parts. Proprioception and cutaneous senses are particularly relevant to the discussion of 
what happens when a limb is amputated [127]. 
The skin mediates a wide range of sensation thanks to the presence of specific receptors that 
transduce a stimulus into electrical impulses. The type of stimuli that can be transduced are 
pressure, vibration, skin stretch, heat, cold and chemicals. The receptors transducing these 
stimuli are usually classified into three categories: mechanoreceptors, transducing 
mechanical stimuli; thermoreceptors, transducing the temperature information of the 
stimulus; and chemoreceptors, responding to chemicals. Nociceptors are a subtype 
chemoreceptors and mechanoreceptors that responds to stimuli potentially damaging to 
tissue. The experience of pain usually starts with activation of nociceptors. When a receptor 
is activated by a sufficiently strong (supraliminal) stimulus, it will send the transduced 
information along the ascending pathway to which it belongs. Nociceptive, temperature, itch 
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sensations and crude touch follow the spinothalamic tract (in the anterolateral column of the 
spinal cord) (Figure 8.B [128]) which crosses the midline in the spinal cord and ascend the 
nervous system in the contralateral side. Conversely fine touch, vibration and proprioception 
follow the dorsal column–medial lemniscus pathway (Figure 8.A) which crosses the midline 
more rostrally at the level of the medulla, thus ascending the spinal cord on the ipsilateral 
side. Because of this special arrangement, spinal hemisection causes a dissociated sensory 
loss of contralateral pain and temperature sensations, and ipsilateral of fine-touch perception. 
Both spinothalamic tract and the dorsal column-medial lemniscus pathway consist of a chain 
of three neurons to convey information from periphery to cerebral cortex. The first order 
neuron is in the dorsal root ganglia (DRG) and enters the spinal cord via dorsal horns, then 
following its specific pathway.  
First order neurons belonging to the mechanosensory pathway, once in the dorsal horn of the 
spinal cord continue to ascend the nervous system following the ipsilateral dorsal column up 
to the brainstem where they then synapse in the caudal medulla with the second order 
neurons. As already mentioned, here the second order neurons shift to the contralateral side 
and ascend to the thalamus where they synapse again. From here the pathway continues 
bringing the information to the primary somatosensory cortex (S1), in the postcentral gyrus. 
The S1 is subdivided into four Brodmann’s areas (BA), namely 3a, 3b, 1, and 2., which are 
somatotopically organized—that is, the sensory signals are represented according to where in 
the body they come from (Figure 9 [129]). BA 3b and BA 1 receive information from receptors 
in the skin, and BA 3a and BA 2 receive proprioceptive information from muscles and joints, 
but there are extensive interconnections between these areas. 
First order neurons synapse with the second order in already in the dorsal horn of the spinal 
cord. From that synapsis, the second order fibers cross the midline and ascend the 
contralateral anterolateral column of spinal cord, projecting to several different structures in 
the CNS. This broad array of central targets forms an extensive network, also known as pain 
matrix, that contributes to different aspects of how pain is processed, making pain a 
multidimensional experience (Figure 10 [130]). In particular, the different central structures 
that are part of the pain matrix can be group into two main systems: one system mediating 
the sensory-discriminative aspects of pain perception and the other conveying information 
about the affective-motivational aspects [131].  
The sensory-discriminative system processes location, intensity and quality of the noxious 
stimulus. Secondary neurons ascending the anterolateral column of the spinal cord project to 
the thalamus where they make synapse with third order neurons which in turn distribute the 
signals to S1, respecting the somatotopic arrangement, and secondary (S2) somatosensory 
cortex [132]. The affective-motivational system is instead responsible for mediating 
unpleasant feelings and autonomic activations that accompany the exposure to nociceptive 
stimulation. Second order neurons belonging to this system project to targets in the reticular 
formation, the superior colliculus, the periaqueductal grey, the hypothalamus and the 
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amygdala. Another important target is the thalamus from which third order neurons depart 
and reach the anterior cingulate cortex (ACC) and the insular cortex (IC) [132].  
This view of pain being mediated by two separate systems is consistent with the results of 
brain imagining studies that have been able to separate the relative contribution to pain 
perception. By using hypnosis directed to increasing or decreasing the perceived intensity of 
the burning sensation produced by submerging a subject’s hand in painfully hot water, it was 
found that pain-related activation S1 was modulated [132]. Conversely, hypnosis directed to 
change the unpleasantness of the perceived sensation had no effect on S1 but produced 
robust modulation of the activation of ACC, directly correlated to the perception of 
unpleasantness [133], [134].  
Top-down modulation of pain  
The perception of pain is also subject top-down modulation, in which higher order brain 
functions can suppress or amplify sensory information coming from lower order mechanisms. 
This is possible thanks to descending pathways where several brain areas including the ACC 
 
Figure 8: Ascending sensory pathways. A) the dorsal column-medial lemniscal pathway, which carries 
mechanosensory information from the posterior third of the head and the rest of the body. Information 
from the face is carried by the trigeminal portion of the mechanosensory system. B) The discriminative 
pain pathway mediating aspects of pain and temperature for the body. Source of the image [128] 
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and IC, the amygdala and the hypothalamus, project to the periaqueductal grey, which in turn 
regulates the transmission of nociceptive information. For example, it was found that 
maintaining attention to pain can worsen it [135] whereas distraction can alleviate it [136]. 
Another factor that is thought to significantly worse pain is pain catastrophizing, defined by 
Sullivan as “an exaggerated negative mental set, brought to bear during actual or anticipated 
painful experience”[137]. Distraction was found to be particularly efficacious in relieving pain 
in these patients. Several studies have also investigated the effect of expectation on pain 
experience indicating that expecting a pain stimulus exacerbate the actual experience. 
Similarly, expecting pain relief can ameliorate pain in what is known as placebo effect. The 
placebo effect is a physiological response following the administration of an intervention, 
relief is at least partially due to the brain’s own descending modulation circuit [138]. The 
effects of placebo are real and brain imaging studies have been able to show reduced activity 
in areas usually involved in pain processing [139] suggesting that this effect is due to the 
release of endogenous opioids [140]. 
Finally, another mechanisms for pain modulation initially proposed by Melzack and Wall as 
gate theory of pain, consists in the modulation of information coming from nociceptive fibres 
at the level of the spinal cord by the interaction with mechanoreceptive afferences and the 
circuitry within the dorsal horns [141]. 
The multitude of areas and targets at all levels of the nervous systems that are involved in 
pain perception suggests that the full experience of pain is mediated by a cooperative 
distributed network of brain areas that are often referred to as pain neuromatrix. It should 
not be surprising then that pain is a multidimensional subjective experience with sensory, 
emotional, affective and cognitive components.  
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Figure 9: Sensorimotor maps. A) Dorsal view of the central sulcus (highlighted in red). B) Sagittal section (along the 
longitudinal fissure) of precentral and postcentral gyri to highlight the subdivision in Brodman areas. C) Division of 
sensory (left) and motor (right) functions in the cerebral cortex. Adapted from Penfield and Rasmussen, 1950 [129]) 
 
Figure 10: The experience of pain. A) A flow diagram showing how the anterolateral system supplies 
information to different parts of the brainstem and forebrain. B) Detail of the cortical target of the 
sensory-discriminative (green) and affective motivational (yellow) system. Sagittal view of the brain 
adapted from [130] 
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Neuropathic pain 
The International Association for the Study of Pain (IASP) defines nociceptive pain as the pain 
occurring with a normally functioning somatosensory nervous system in presence of actual or 
threatened damage to non-neural tissue and is due to the activation of nociceptors. This 
definition is meant to emphasize by contrast the abnormal function seen in neuropathic pain, 
which is instead defined as pain arising from lesion or disease of the somatosensory nervous 
system (Definitions last updated on December 14, 2017).  
Nociceptive pain is a physiological sensation aimed at protecting the organism by preventing 
injury. This is achieved with two strategies: a withdrawal strategy in which a reflex 
automatically removes the body from the source of the noxious stimulus; and with a 
protective strategy in which an unpleasant sensation induces the organism to implement 
complex behavior to avoid further exposure to the source of pain [142]. Another mechanism 
that further enhances the protective approach is sensitization of the nociceptive system, 
known as peripheral sensitization, in which repeated, or particularly intense noxious stimuli 
bring the nociceptors to be more sensitive. A nociceptive stimulus is still necessary to trigger 
pain; however, the firing threshold of the nociceptors is lower, making them fire following 
nociceptive stimuli that would normally not be perceived. His condition of heightened 
sensitivity is also known hyperalgesia. As the injured tissue heals the sensitivity of the 
nociceptors goes back to normal levels [127].  
It can happen however that pain loses its protective function and even non-noxious stimuli. 
Central sensitization is initiated by activity in nociceptors; however, the effects generalize to 
other inputs that arise from low threshold mechanoreceptors (allodynia). This feature of 
central sensitization is caused by means of neural plasticity in the CNS, which changes the 
sensory response elicited by normal inputs, including those that usually evoke innocuous 
sensations. Since this effect is cause by plastic changes in the neurons, pain might be 
experienced long after. Neuropathic pain reflects both peripheral and central sensitization 
mechanisms [143]. 
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Motor control 
Under normal conditions, both voluntary and involuntary movements are the result of 
patterns of muscle contraction, which in turn are directed by the activity of neural circuits 
both in the brain and spinal cord. Voluntary movements of the limbs are made possible by 
skeletal muscles, innervated by lower motor neurons (LMN), that have cell bodies in the 
ventral horn of the spinal cord grey matter. LMN activation is controlled by local circuits within 
the spinal cord, which receive direct input from sensory neurons (to mediate the sensory-
motor reflexes) and are tightly interconnected. The local circuits of LMN are modulated by 
upper motor neurons (UMN), whose cell bodies are situated in brainstem centers (such as 
vestibular nuclei, superior colliculus, reticular formation) as well as in the cerebral cortex 
which controls the volitional aspect of the movements. Among the cortical areas involved in 
motor control, the primary motor cortex (M1) and a collection of premotor areas in the frontal 
lobe, are responsible for planning and controlling complex sequences of voluntary 
movements. M1, similarly to S1, is arranged according to a somatotopic maps that represent 
a point to point connection between a certain body part and its respective representation in 
the cortex. The map seems to 
represent all the movements that the 
specific body part can make rather 
than individual muscles. Also, the 
larger a cortical area is dedicated to a 
part of the body the more 
movements can be performed [144]. 
The descending pathway that 
contains the axons of the UMN 
bringing them to synapse with LMN in 
the spinal cord is called corticospinal 
tract (Figure 11 [145]), which is the 
largest descending tract present in 
humans [146]. The corticospinal tract 
is divided into anterior and lateral 
components. The anterior 
corticospinal tract innervates both 
contralateral and ipsilateral axial and 
proximal limb muscles, securing 
control of posture and balance. The 
lateral component of the 
corticospinal tract innervates the 
contralateral distal limb muscles thus 
mediating skilled movements. The 
decussation of the corticospinal tract 
takes place at the level of the caudal 
medulla. 
 
Figure 11: Descending motor pathways. Corticospinal and 
corticobulbar tracts. Source of the picture [145]. 
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Finally, the neural circuitry in the basal ganglia and cerebellum regulates the upper motor 
neurons, by projecting to M1 via relays in the ventrolateral thalamus and mediating initiation 
of movements and regulating the performance [127]. 
The effects of amputation on the nervous system  
Amputation deprives the nervous system of the sensory inputs originating from the detached 
body part and causes changes at every level of the nervous system. The dynamic ability to 
change and adapt is called plasticity and can take place both in the periphery [147] and in the 
central nervous system [127]. This section attempts to clarify the consequences of amputation 
on the PNS and CNS, and how the mechanisms involved might contribute to the perception of 
PLS and PLP. 
Postamputation pain 
Postamputation pain is a composite phenomenon that can have two stages: an acute pain 
stage sometimes followed by a chronic pain stage. Two types of acute postamputation pain 
may occur. The first is the pain in the amputated stump, or RLP, and the second is the pain 
perceived in the missing limb (PLP): these two types of pain are often confused. The acute 
postoperative pain is due to the damage of the tissue and nerves and it should resolve itself 
by healing. However, both acute RLP and acute PLP can become chronic. Chronic RLP can have 
both nociceptive (somatic) and neuropathic origins [148]. Neuropathic mechanisms include 
the presence of a neuroma, development of Complex Regional Pain Syndrome, heterotrophic 
ossification or mosaic neuralgia [78]. Nociceptive mechanisms are connected to the failure of 
the stump to heal and involve infection, failure of flap closure, bone spurs, vascular 
insufficiency, or soft tissue inflammation around the prosthesis [77]. Figure 12 shows an 
adapted version of the proposed classification of postamputation pain phenotypes proposed 
by Clarke et al. [77].  
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Neuroma pain 
Among the different phenotypes of RLP, neuroma pain deserves further attention since it can 
be perceived in the missing limb and thus considered as PLP by definition of the IASP. 
Diagnosing a neuroma as a source of RLP is however useful when formulation a treatment 
plan [149]. After disruption of a nerve, axons regenerate and sprout often in an unregulated 
fashion resulting in a tangle containing axons (both A and C fibres), Schwann cells, endoneurial 
cells, perineurial cells in a dense collagenous matrix and fibroblasts [120]. Wall and Gutnick 
[150] showed ongoing spontaneous activity in neuromas, with additional afferent activity, in 
terms of increased firing rate, generated mechanically (by applying pressure) or chemically 
(by noradrenaline). Sherman [151] later showed that pain in the phantom can be initiated by 
spasms in muscles surrounding the neuroma, which would be analogous to applying direct 
pressure. Further, Nyström and Hagsbarth [152] demonstrated with microelectrode 
recordings of peripheral nerves in a human amputee, that when using anesthetic block the 
increased activity evoked by taps on the neuroma was eliminated together with the associated 
increase of PLP. In contrast, the spontaneous impulse activity in the nerve fascicle was left 
unaltered by anesthesia together with the spontaneous background PLP. Neuromas can also 
lead to central sensitization thus causing pain perception in response to stimuli that normally 
would not provoke pain (e.g. signals coming from fibres other than nociceptive) [153]. The 
diagnosis of neuroma pain is based on palpation or application of pressure on a focal area of 
tenderness resulting in a distally radiating pain in the distribution of the peripheral nerve or 
increase in pain perceived in the stump or phantom.  
Stump neuromas have often been hypothesized to be the cause of PLP, and this might indeed 
be the cause for some patient given the chain of changes in the CNS that a neuroma might 
trigger (e.g. such as central sensitization). However, neuroma cannot explain the occasional 
 
Figure 12:Classification of postamputation pain. Chart showing the classification of different phenotypes of 
postamputation. 
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reports of PLP present immediately after amputation, before a neuroma could possibly form 
and therefore, neuroma cannot be considered the direct mechanism behind PLP. Another 
counterexample is provided by some rare case of PLP in congenitally absent limb [154]. 
Further, despite the fact anesthesia applied to a neuroma can reduce PLP, this does not seem 
to be the case for all the subjects [152], [155]. Pain perceived in the phantom that is not 
ascribable to neuroma pain is the type of pain of central interest in this thesis. 
Peripheral mechanisms 
Early theories attributed the PLS and PLP to the irritation of peripheral nerves. However, these 
theories have been abandoned over time in light of solid evidence showing that no anesthetic 
block can universally abolish PLS and/or PLP [155]. Further contributing to the dismissal of 
PNS as culprit for PLS and PLP, anesthesia was also used in healthy subjects to actually induce 
phantom limbs [73]. Nevertheless, more recent research as brought the attention to a 
peripheral mechanism that has so far been unappreciated as a driver of PLP and PLS, namely 
the ectopic firing of the dorsal root ganglia (DRG). The DRG contain the cell bodies of the first 
order afferent neurons and belong to the PNS. Following amputation, the DRG lose their 
receptors of nerve endings and might start firing spontaneously (ectopically), which in turn 
can amplify the discharges coming from the residual limb or initiate depolarization of 
neighboring neurons. Vaso et al. [156],  by performing blockade of the DRG, showed a 
dramatic relief PLP and a decrease in PLS, thus suggesting that the PNS could be indeed 
considered as a viable component for a theory of PLP. Finally, events and changes taking place 
in the PNS may still have a causal role in driving the reorganization of CNS in an experience-
dependent manner, thus leading indirectly to the experience of PLP and PLS [120]. 
Central mechanisms 
Kaas and Merzenich (1984) pioneered the analysis of how cortical maps in S1 respond to 
altered patterned of activity in peripheral nerves in primates. In their work they showed the 
potential for reorganization of adult cortical circuits, which up to that point were thought to 
be immutable. To alter the activity of peripheral nerve, they cut the innervation to a hand or 
amputated a digit. They showed that immediately after the deafferentiation, the cortical area 
corresponding to the deafferented body part was unresponsive. After few weeks however, 
they found that area started to respond to stimulation of neighboring body regions. In the 
case of digit amputation for instance, the representation of the remaining fingers was found 
to invade the deafferented cortex, in a process also known as functional remapping [157]. 
Pons et al. [41] later discovered more extensive remapping, where the cortical areas related 
to the deafferented limb became responsive to facial stimulation. Functional remapping has 
been shown to take place also in the thalamus [158], the brainstem [159] and the spinal cord 
[160], thus suggesting that some of the cortical reorganization might be indeed induced by 
the plasticity of subcortical structures [161], [162]. However, it has also been shown that 
changes at subcortical levels originate in the cortex, thanks to connections to the thalamus 
and lower structures [163], thus making it difficult to establish a clear direction of causality  
Following Pons’ observations, Ramachandran (1992) and colleagues hypothesized that 
phantom limbs could be the perceptual counterpart of this functional remapping and 
investigated this hypothesis by stimulating the face of two amputees, who consequently 
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perceived PLS [47]. Several brain imaging studies have demonstrated a shift of the mouth 
representation into the hand representation in S1 of upper limb amputees [47], [54], [155]. , 
which has been used to explain phantom phenomena in the context of postamputation 
reorganization. For example, Flor et al. [54] also showed that the perceptual correlated to this 
reorganization is PLP: the larger the invasion of the mouth into the hand representation, the 
more intense the pain. This cortical shift, together with PLP, completely disappeared in some 
patients by using brachial plexus anesthesia that eliminated the peripheral input. This suggests 
that at least in some cases, cortical reorganization and PLP are maintained by the 
periphery.[155]. Contributions of subcortical structure to the perception of phantom limbs 
have been shown by Aydin et al. [164] who reported a case of a woman who had suffer from 
PLP for 60 years and experienced the a progressive decrease in PLP in parallel with the growth 
of an intraspinal tumor. PLP gradually reappeared after resection of the tumor. Spinal 
anesthesia has been implicated in the development of PLP, causing it in patients who were 
previously pain-free [165]. However this doesn’t seem to be a reliable effect and the evidence 
is sparse [166]. Finally, thalamic micro stimulation and recordings in human amputees have 
shown that the reorganizational changes occurring at the thalamic level are closely related to 
the perception of PLS and PLP. Thalamic stump representation was found unusually large. 
Moreover, in amputees with phantom limbs, thalamic stimulation could reliably evoke PLP 
and PLS even by stimulating those areas responsive to the stump, consistent with the 
hypothesis that the deafferented neurons remain functionally related to the missing limb. 
More recent research conducted with ultra high-field (7T) fMRI confirmed the findings of an 
earlier pioneering somatosensory evoked potential study that evidenced the continued 
presence of the limb representation in the deafferented cortex years after amputation [167]. 
In the recent study, Kikkert et al. (2016) showed instead that amputees experiencing highly 
vivid phantom sensations maintained precise individual finger topography in S1, even decades 
after amputation and total absence of sensory input [168]. This finding, together with the 
evidence form structural and functional brain imaging studies corroborate the hypothesis that 
S1 has limited capacity for reorganization, and that instead, the functional changes previously 
observed in S1 following deafferentation could be attributed to reorganization in subcortical 
areas in the afferent pathway, particularly in the brainstem [169]. 
Motor control of phantom limbs  
As already mentioned in Chapter 3, amputees can perceive kinetic sensations of voluntary or 
involuntary phantom movements [97]. Further, a series of studies investigating both 
neurological and behavioral aspects of phantom motor control have confirmed that phantom 
movements are indeed authentic and natural. From a behavioral point of view evidence 
comes from studies investigating the inter-limb coordination of intact hands and phantoms. 
Normally, untrained healthy controls when moving both hands simultaneously experience 
strong coupling effects and neither of the two hands can perform independent actions. This 
effect has been shown to exist in amputees with phantom limbs when performing the line-
circle task, namely drawing a line with either the phantom hand or intact hand and 
simultaneously drawing a circle with the other side [170]. In the same study it was shown that 
amputees that could not move their phantom or simply imagined the phantom movement did 
not show the coupling effect.  
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Neurological evidence comes from a broad series of studies. For example, intraneural 
recordings of severed nerves formerly innervating the hand, have shown motoneuron activity 
associated with missing limb movements. Electrical stimulation of the same nerve was also 
used to elicit sensations of touch , joint movement and position in the missing limb [171]. 
Moreover, Electromyography (EMG) activity in stump muscles has also been used as a 
biomarker of volitional phantom limb movement. In particular, Reilly et al. [172] recorded 
EMG activity from the residual limb muscles of seven upper-limb amputees while they 
voluntarily produced different phantom limb movements and showed that these phantom 
movements produced characteristic and repeatable patterns of EMG activity, except for a 
subject with a frozen phantom who showed always the same EMG pattern regardless of the 
type of movement attempted. In the same study, Reilly et al. [172], induced temporary 
ischemic block in three amputees in order to eliminate the contribution of stump muscles to 
phantom limbs movements. This reduced or eliminated the ability to voluntarily move the 
phantom limb, while reducing also the amplitude of stump muscle EMG activity. This suggests 
that a motor command must arrive at the selected stump muscles and generate ascending 
afferent sensory feedback for the amputee to experience movement in the phantom limb. 
In another study conducted by the same group [173], M1 area of the deafferented hand was 
stimulated by using transcranial magnetic stimulation (TMS). This resulted in sensations of 
movement in the phantom hand accompanied by motor evoked potentials in stump muscles. 
Further, phantom limb movements that were not accessible by the amputee under normal 
conditions, could be executed under TMS, thus suggesting that the inability to voluntarily 
move the phantom limb is not due to a loss of the corresponding movement representation 
but its impairment. Taken together, these findings seem to suggest that the representation of 
phantom movements is preserved within M1 and are expressed by retargeting residual limb 
muscles [174]. The mechanisms allowing for this retargeting and the level at which this 
happens (i.e. centrally or in periphery) are yet to be elucidated. However Reilly at al.,[174] 
hypothesized that M1 representations of the deafferented limb survives automatically after 
amputation, and under certain circumstances, spinal, subcortical, and/or cortical 
reorganization allow these preserved representations to express themselves within a new 
sensorimotor loop by contacting stump muscles, which by activating produce a sensory 
afference in return. They further suggest that such mechanism could provide advantage to 
the amputee in the form of PLP relief. In a follow-up brain imaging study conducted by the 
same group, Raffin et al. [11] conducted a study that provided evidence for a link between 
phantom motor control and PLP. They showed that the amputated limb representation was 
preserved in M1 and symmetrical to the representation of the healthy side. Further they 
showed that poorer voluntary control and higher levels of pain in the phantom limb were 
linked lip and elbow representations reorganization, which were found to be shifted towards 
the amputated hand area. Other studies have corroborated the evidence that worse chronic 
PLP is associated to poorer and/or slower phantom motor control [12], [175], [176]. 
Additional support for the hypothesis that M1 representation of the hand is preserved 
following deafferentation comes from other brain imaging studies showing that movement-
related activity of the phantom hand in amputees is compatible to that of two-hander controls 
when moving their non-dominant hands [55], [168]. However, in contrast to the findings of 
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Raffin et al.[11] with respect to PLP, Makin et al.[55] show that PLP is correlated instead to 
persistent representation of the phantom motor representation which is maintained by the 
experience-dependent plasticity induced by pain itself. They further found that PLP is 
associated with reduced interhemispheric functional connectivity between the phantom 
cortex and intact hand cortex, hypothesizing the experience of pain as a contributor to the 
functional decoupling from the sensorimotor network.  
In this chapter, the main aspects involved in the perception of phantom limbs and PLP, 
together with an overview of what is currently known regarding the neural basis of phantom 
motor control were summarized. At the current state, it seems that both peripheral and 
central mechanisms are involved these phantom phenomena. Recent findings showing 
dramatic relief from both PLP and PLS following blockade of the DRG [156] suggest that role 
of peripheral factors in PLP might have been so far underestimated, however to conclusively 
show the PLP depends solely on ectopic discharges from the PNS further evidence is required. 
Central aspects of phantom phenomena are more contradictory and involve reorganization of 
S1 and S2 (maladaptive or experience-dependent) and possible reorganization at every 
subcortical level.   
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CHAPTER 5 
 
CHAPTER 5. Theories of pain and hypothesis of PLP 
 
 
The present chapter provides an overview of the current theoretical frameworks and the most 
plausible hypothesis accounting for the origin and maintenance of PLP.  
Neuroplasticity 
Maladaptive plasticity and cortical reorganization theory 
The cortical reorganization theory emerged following Flor et al. (1995) seminal work, where a 
strong correlation between the intensity of PLP and the amount of cortical reorganization was 
found [54]. The reorganizational changes that they observe related to the invasion of the S1 
deafferented cortex from neighboring cortical representations. Other studies replicated the 
finding in S1 [177], [178] and further showed similar reorganizational patterns into M1 cortex 
[179]. Later it was observed that reduction of PLP was accompanied by a rather quick 
normalization of the cortical representation [155]. Further reduced reorganization and PLP 
was also shown after functionally relevant sensory discrimination training [180] and intensive 
use of a myoelectric prosthesis [181]. Nonetheless a recent systematic review of fMRI studies 
assessed the robustness of the evidence in favor of the maladaptive plasticity model and 
found only limited evidence in support of the theory and highlighting the need for further 
studies, in particular longitudinal studies assessing pain-modulating intervention [182]. 
Importantly, the cortical reorganization theory does not imply that invasion of the 
deafferented cortex leads to a loss of phantom representation. This has been demonstrated 
by brain imaging data showing maintained SM1 phantom limb representation within the 
original cortex together with the typical link between PLP and cortical reorganization 
postulated by the theory [183]. This view is also consistent with the suggestion advanced by 
Merzenich et al. [40] that reorganization following sensory input loss does not dismiss the 
possibility for coexistence of the original function. 
The findings of Flor et al. [54] themselves cannot establish a causal link between 
reorganization and PLP. However, the authors proposed that loss of sensory inputs to the 
phantom cortex, an adaptive process meant to recover functionality takes place. In amputees 
with PLP this process may have become maladaptive and associated to pain maintenance. The 
maladaptive changes may also have origins in lower level structures. What remains unclear in 
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the maladaptive cortical reorganization model is the explanation of precise mechanism (direct 
causality of mediation by a third party) at the basis of the strong correlation between PLP and 
cortical reorganization. 
Experience-dependent plasticity driven by pain 
This theory, known as the persistent representation model, was first proposed in Makin et al. 
(2013), as interpretation of their fMRI study comparing PLP patients with congenital one-
handers without PLP and healthy controls. The study found that stronger activations in SM1 
following phantom execution were correlated with the amount of PLP experienced by 
amputees. They also showed that the amount of grey matter volume was reduced in paitents 
with pain, and this structural change was also correlated to PLP. Finally, the same study also 
showed a reduction of interhemispheric connectivity between the SM1 phantom and intact 
hand representation in presence of PLP. A behavioral counterpart of this effect could 
potentially be the reduced bimanual coupling of patient with PLP presented by Osumi et 
al.[184]. The theory attributes all the effects found in that study to experience-depended 
plasticity driven by PLP, which in turn could be triggered either bottom-up peripheral inputs 
(e.g. ectopia in the DRG [156]) or top-down inputs coming from other pain-related brain areas 
(e.g. insula). By being the experience that drives plasticity, PLP maintains the local cortical 
representation and disrupts the functional connectivity between the missing hand cortex and 
the sensorimotor network [185]. Coherently with this hypothesis, studies conducted by the 
same group showed that higher PLP correlates with worse motor control of the phantom limb, 
which in turn produces stronger SM1 activation [12] and induced PLP relief is conversely 
associated with decreased activity [186]. 
Neuromatrix 
In 1990 Melzack proposed the neuromatrix theory to account for the perception of phantom 
limbs and associated pain [95]. However, the theory become later on used to account for body 
perception, somatic sensations and pain perception [187]. What brought Melzack to propose 
the neuromatrix theory was the impossibility of identifying phantom phenomena with S1, due 
to the failure of procedures such as S1 ablation for PLP treatment to eliminate both phantom 
limbs and PLP. Instead of considering single stimuli to different areas of the brain as the 
ingredients of conscious perception, he proposed that the experience of the body emerges 
from a genetically built-in matrix of neurons for the whole body that he renamed “the self-
body neuromatrix” (Figure 13). Practically, this neuromatrix has been hypothesized to be a 
network of neurons in several brain areas including the thalamus and somatosensory cortex, 
the reticular formation, the limbic system, and the posterior parietal cortex, that are the 
anatomical substrate of the self. Said neuromatrix takes several different inputs and it outputs 
characteristics nerve-impulse patterns that account for everything we feel (neurosignatures). 
The landmark feature of the neuromatrix theory is that a single input can only trigger or 
modulate a neurosignature and cannot directly cause perception. The implications of this 
theory for pain are that a noxious stimulus might not be necessarily felt (it might not trigger a 
pain neurosignaure) and in the same way the pain neurosignature might be active without a 
stimulus that triggered it. Similarly, an amputation causes changes in the sensory inputs that 
37 
 
lead to an altered neurosignature which in turn could result in phantom phenomena (painful 
and non).  
A limitation of the neuromatrix theory is that although it offers a complex account of pain, 
potentially explaining every aspects, this theory is highly unspecific and hard to test 
empirically because it does not give an account of how everything actually happens (e.g. how 
neurosignatures are formed and activated). Consequently, it does not give any clear direction 
on how to treat PLP: it just emphasizes the need to treat PLP with a holistic approach that 
encompasses the equally important cognitive, affective and sensory factors.  
 
Stochastic entanglement 
Recently a new hypothesis was proposed by Ortiz-Catalan [10]. This hypothesis, named 
stochastic entanglement, could be regarded as an evolution of the neuromatrix theory of pain 
with regards to the existence of pain neurosignatures, but accounting for the dynamics leading 
to their unintended activation. According to the hypothesis, the nervous system can be 
assimilated to a complex dynamical system, that if seriously perturbated (i.e. by amputation) 
enters a susceptible state (disequilibrium) where different brain networks (e.g. sensorimotor 
network and pain network) can become unintentionally entangled due spurious firing 
coinciding temporally and spatially. For example, if the pain neurosignature is entangled with 
the sensorimotor network, PLP could be experienced. Similarly to Melzack’s neuromatrix 
theory, the stochastic entanglement can fully account for the multidimensionality of the 
experience of pain, including emotional and cognitive components. A fundamental feature of 
 
Figure 13: Pain neuromatrix. Factors that contribute to the patterns of activity generated by the body-self 
neuromatrix, which comprises sensory, affective, and cognitive neuromodules. The output patterns from the 
neuromatrix produce the multiple dimensions of pain experience as well as concurrent homeostatic and 
behavioral responses. Source [187]. 
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this hypothesis is that the long-term evolution of the system depends on its initial conditions, 
thus accounting also for the portion of patients who never develop PLP (which is something 
currently unaccounted for by other hypothesis and theories of PLP). Another important 
feature of the stochastic entanglement is the clear prediction that PLP should be relieved by 
undoing the entanglement, in a process akin to the inverse of Hebb’s law “neurons that fire 
apart wire apart”. Ways of disentangling pain and sensorimotor circuitry could be by 
reengaging the sensorimotor network in a functionally meaningful way. Phantom Motor 
Execution (PME), the exercise of voluntary and skilled phantom movements, is the proposed 
way to achieve this. 
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CHAPTER 6 
 
CHAPTER 6. Summary of Included Papers 
 
 
This chapter provides a brief summary of the papers that constitute the basis for this thesis. 
Full versions of the papers are included in Part II.  
Paper A 
E Lendaro, E Mastinu, B Håkansson, M Ortiz-Catalan 
Real-time classification of non-weight bearing lower-limb movements 
using EMG to facilitate phantom motor execution: engineering and 
case study application on phantom limb pain Published in Frontiers in 
Neurology, 2017, 8:470. 
DOI: https://doi.org/10.3389/fneur.2017.00470 
The evidence in support of PME as an effective way to treat PLP was initially obtained only on 
upper limb amputees. However, lower limb amputees represent the vast majority of cases of 
limb loss. In order to investigate the effectiveness of PME in lower amputees, the system in 
use for treating upper limb patients needed to be adapted. The first aim of this study was to 
enable PME aided by MPR and VR/AR in lower limb amputation. This resulted in the proposal 
and validation of a new recording configuration that is a more user-friendly to record EMG 
signals from the lower limb. Further, the second aim of the paper was to provide evidence 
that PME is a viable option for PLP relief in lower limb amputees, and therefore the successful 
treatment of the first lower limb patient conducted. Enabling and verifying the treatment for 
lower limb patient was an instrumental step for the RCT on the use of PME, the protocol of 
which is presented in paper B. 
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Paper B 
E Lendaro, L Hermanson., H Burger , C Van der Sluis C., B McGuire, M Pilch, L Bunketorp-
Käll, K Kulbacka-Ortiz, I Rignér, A Stockselius, L Gudmundson, C Widehammar, W Hill, S 
Geers, and M Ortiz- Catalan 
Phantom Motor Execution as a treatment for Phantom Limb Pain: 
Protocol of an international, double-blind, randomized, controlled 
clinical trial Published in British Medical Journal Open, 2018, 8:e021039 
DOI: http://dx.doi.org/10.1136/bmjopen-2017-021039 
Despite the large number of treatments described in the literature to treat PLP, none of them 
has proven to be decisively effective for treating the condition, and at present, guidelines for 
the treatment of patients in this situation are absent. This can be largely attributed to the 
scarcity of RCTs on such treatments. In this paper, we designed the protocol for a double blind, 
international, multi-sited RCT on the use of PLP in order to gather unbiased and stronger 
evidence of the actual effect of PME. This is to the best of our knowledge, the largest 
international clinical trial on PLP ever conducted.  
Paper C 
E Lendaro, A Middleton., S Brown, M Ortiz-Catalan 
Out of the Clinic, Into the Home: The In-Home Use of Phantom Motor 
Execution aided by Machine Learning and Augmented Reality for the 
treatment Phantom Limb Pain Published in Journal of Pain Research, 
2020, 13, 195. 
DOI: https://doi.org/10.2147/JPR.S220160 
Preliminary evidence suggests that in order to maintain long term PLP relief, periodic 
rehearsal of the phantom motor skill is necessary. In this study we enabled the treatment to 
be self-administered and carried out at home and we investigated how patients adapted to 
the regime. The purpose here was to explore the benefits and the challenges encountered in 
translation from clinic to home use with a mixed-methods approach, employing both 
quantitative and qualitative methods from engineering, medical anthropology, and user 
interface design. 
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CHAPTER 7 
 
CHAPTER 7. Concluding Remarks and Future Works 
 
 
Looking back at the work done so far and presented in this licentiate thesis, a theme emerges: 
this time has served to “set the stage” for the final PhD defense. In paper A, we have extended 
the use of PME to lower limb patients, this step was necessary in order to carry out the RCT. 
Paper B has presented the preparatory work for this clinical trial which is currently carried out 
and in completion phase: most of the planned patients have already been treated and the last 
follow-up assessment are expected to carried out in March 2021. Finally, paper C enabled PME 
to be used by the patients themselves, at their homes, investigating the benefits and 
challenges of a transition from the clinic to home, and served to identify what could be 
improved in order to ensure treatment adherence. 
The future work involves the completion and presentation of the results of the RCT. However, 
as I briefly mentioned in Chapter 1 when providing the motivation for this thesis, having a way 
to modulate PLP represents a unique tool for studying the neural basis of PLP. Capitalizing on 
this tool, we are currently running brain imaging studies based on fMRI and 
electroencephalography, which will be the main focus of the work lying ahead. 
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of Technology, Gothenburg, Sweden, 2 Integrum AB, Mölndal, Sweden
Phantom motor execution (PME), facilitated by myoelectric pattern recognition (MPR) 
and virtual reality (VR), is positioned to be a viable option to treat phantom limb pain 
(PLP). A recent clinical trial using PME on upper-limb amputees with chronic intractable 
PLP yielded promising results. However, further work in the area of signal acquisition 
is needed if such technology is to be used on subjects with lower-limb amputation. 
We propose two alternative electrode configurations to conventional, bipolar, targeted 
recordings for acquiring surface electromyography. We evaluated their performance 
in a real-time MPR task for non-weight-bearing, lower-limb movements. We found 
that monopolar recordings using a circumferential electrode of conductive fabric, 
performed similarly to classical bipolar recordings, but were easier to use in a clinical 
setting. In addition, we present the first case study of a lower-limb amputee with 
chronic, intractable PLP treated with PME. The patient’s Pain Rating Index dropped 
by 22 points (from 32 to 10, 68%) after 23 PME sessions. These results represent a 
methodological advancement and a positive proof-of-concept of PME in lower limbs. 
Further work remains to be conducted for a high-evidence level clinical validation of 
PME as a treatment of PLP in lower-limb amputees.
Keywords: phantom limb pain, virtual reality, myoelectric control, electromyography, pattern recognition, 
neurorehabilitation, phantom motor execution
inTrODUcTiOn
Following an amputation, it is common for the patient to perceive the missing limb as if it is still 
part of the body. The phenomenon, known as phantom limb, is accompanied by a wide range of 
sensory perceptions that can vary among patients but are collectively referred to as phantom sensa-
tions (such as warmth, cold, or kinesthesia) (1). Amputees can often experience painful sensations 
in their phantom limb, giving rise to a condition commonly known as phantom limb pain (PLP). 
The pathogenesis of PLP is still controversial, and there is currently no treatment regarded as 
generally effective. Therefore, PLP remains a major clinical challenge (2, 3).
FigUre 1 | Sketch of the three electrode configurations. (a) Untargeted 
monopolar configuration, (B) targeted bipolar configuration, (c) targeted 
monopolar configuration, (D) common circumferential electrode, and  
(e) reference electrode.
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Recently, promising results on the treatment of PLP were 
achieved with a novel technology tested on subjects with upper-
limb amputation (4). This treatment, firstly introduced by Ortiz-
Catalan et  al. in 2014 (5, 6), aims at promoting the execution 
of phantom movements, and hence the name phantom motor 
execution (PME). Other contemporary research efforts have 
brought about a number of non-pharmaceutical initiatives to 
treat PLP focusing on voluntary or imagined phantom move-
ments (7–11). PME distances itself form these approaches by 
the certainty it provides of phantom movements being actually 
executed, while visualized as direct biofeedback with unper-
ceivable delay. This is achieved using a myoelectric pattern 
recognition (MPR) system that renders virtual and augmented 
reality (VR/AR) environments under the control of the subject’s 
phantom limb. For instance, a virtual arm superimposed on a 
live video projection of the patient’s stump can be controlled in a 
similar way as the patient’s arm prior to amputation. The advan-
tage of such a system is twofold. First, the ease of movement of 
the virtual limb is a direct consequence of naturalistic muscular 
patterns of activation owing to the nature of MPR. Second, VR 
and AR environments provide visual feedback that is congru-
ent with the phantom motion executed, thus facilitating motor 
execution (12, 13). Clinically significant improvements on PLP 
(approximately 50% reduction) found in upper-limb amputees 
treated with PME (4) call for this technology to be explored in 
lower-limb amputees suffering the same condition.
For many decades, MPR has been vastly studied for upper 
limbs (14), while advances for lower limbs are relatively recent 
and mostly focused on improving prosthetic control under 
weight-bearing conditions (15–20). However, in the context of 
implementing PME for lower limbs, the interest in MPR lies in 
non-weight-bearing conditions because the patient should be 
able to execute leg movements while sitting in front of a screen. 
More importantly, such movements must be natural, not the 
result of reaction forces. MPR for the non-weight-bearing con-
dition has been attempted in offline (21) and real-time studies 
(22). Notably, Hargrove et al. demonstrated the discrimination of 
eight leg movements (knee flexion/extension, ankle plantarflex-
ion/dorsiflexion, hip rotation medial/lateral, and tibial rotation 
medial/lateral) in both non-amputee and amputee subjects by 
recording surface electromyography (sEMG) signals with bipo-
lar electrodes placed over nine residual thigh muscles (22). The 
adopted procedure for electrode placement and signal collection 
can be challenging in a rehabilitative setting. Primarily, not all 
muscles might be available depending on the level of amputa-
tion. Furthermore, anatomical changes following amputation 
could make it difficult to precisely identify the desired muscles.
We previously proposed two electrode configurations to 
acquire sEMG for MPR of non-weight-bearing movements 
of the lower limb (Figures  1A,C) (23). We compared these 
electrode configurations with the conventional bipolar targeted 
configuration in terms of signal-to-noise ratio (SNR) and offline 
MPR classification accuracy. We found that equally spacing the 
electrodes round the most proximal third of the thigh is a viable 
alternative to bipolar recordings from specific muscles, with the 
additional advantage of facilitating the recording procedure. 
However, MPR offline accuracy does not necessarily correspond 
with real-time performance (24–26). In this work, we validated 
previous offline findings using real-time metrics and performed 
the first clinical evaluation of PME on a lower-limb amputee 
who suffered from chronic, intractable PLP.
Ethical approval for the studies was granted by the ethical 
committee of Västra Götalandsregionen. The participants in 
both studies signed informed consent statements. The patient 
who underwent PME treatment was also informed of possible 
increases in pain, and uncertainty of positive outcomes.
MaTerials anD MeThODs
Part i: classification of non-Weight-
Bearing lower-limb Movements
The Subjects
Twelve non-amputees (five males and seven females, ages 23–30) 
and two amputees participated in the study. One amputee had 
a unilateral transfemoral amputation (70 years old and 35 years 
after amputation), whereas the other had a unilateral, transtibial 
amputation (72  years old and 22  years after amputation). The 
transfemoral amputee was trained in using the MPR system, 
while the transtibial amputee was a novice.
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Electrode Placement
Non-amputees sat on a raised seat, allowing their feet to hang 
freely. This precaution was taken to ensure that patterns used 
for discriminating movements of the foot (ankle plantarflexion/
dorsiflexion) were not generated by ground reaction forces. 
In one experimental session, sEMG signals using a targeted 
bipolar configuration (TBC) and a targeted monopolar con-
figuration (TMC) were simultaneously acquired. In a different 
session, an untargeted monopolar configuration (UMC) was used 
(Figure 1). Amputees participated in both experimental sessions 
on two different days, and non-amputees were randomly divided 
into the two sessions (six each). Figure  1 shows the recording 
configurations as follows:
•	 UMC (Figure  1A): a circumferential electrode made of 
conductive fabric (silver-plated knitted fabric) was dampened 
with a small amount of water to decrease skin-electrode 
impedance and tied around the most proximal third of the 
thigh. Sixteen Ag/AgCl adhesive electrodes (disposable, 
pre-gelled Ag/AgCl, 1-cm diameter) were placed below the 
band (more distally on the leg) and equally spaced around 
the thigh. The gap between the electrodes and the band 
was approximately 4  cm. Differential measurements were 
recorded between each of the electrodes and the common cir-
cumferential electrode (CCE) (Figure 1D). The configuration 
is monopolar, due to the use of the CCE as a reference for the 
other adhesive electrodes.
•	 TBC (Figure  1B): eight pairs of pre-gelled electrodes were 
placed over the following eight muscles at an inter-electrode 
distance of 4 cm: sartorius, tensor fasciae latae, vastus medialis, 
rectus femoris, vastus lateralis, gracilis, the long head of the 
biceps femoris, and semitendinosus. The stump of the trans-
femoral subject was long enough to identify all the muscles.
•	 TMC (Figure 1C): for each pair of electrodes in the TBC, a 
third electrode was placed in between. The CCE was damp-
ened and tied around the proximal third of the thigh. We 
recorded differentially between each of the eight electrodes 
and the average potential of the area covered by the CCE.
A reference electrode used for all recording configurations was 
placed on the contralateral wrist over the distal end of the ulna 
(Figure 1E).
Recording Session
The system used for sEMG acquisition was developed in-house 
and based on the RHA2216 chip (Intan Technologies, USA), 
with embedded filter (a third-order, Butterworth, low-pass 
filter with cutoff at 750  Hz and a first-order, high-pass filter 
with cutoff at 1 Hz). The system amplified the myoelectric sig-
nals from 16 channels with a gain of 200 times, and digitalized 
them with 16 bits of resolution at a 2-kHz sampling rate. Before 
proceeding to data acquisition, sEMG signals from all channels 
were checked to ensure the devise was functioning correctly. 
The data acquisition, signal treatment, pattern recognition, 
and real-time evaluation all used an open-source software 
(BioPatRec) for decoding motor volition using MPR (25).
The participants were instructed to follow a graphical user 
interface showing the movements to be performed (Figure 2), 
along with a progress bar signaling the duration of each contrac-
tion. The recorded movements were as follows: knee flexion/
extension, ankle plantarflexion/dorsiflexion, hip rotation 
medial/lateral, and tibial rotation medial/lateral. The amputees 
were asked to execute the movements as naturally as possible, 
focusing on their phantom leg. All participants were also 
instructed to perform the movements at a comfortable speed, 
avoiding abrupt contractions or jerks, as these would introduce 
motion artifacts in the signals. Once participants reached the 
end of their range of motion, they held the position for the 
remaining part of the contraction time, and then relaxed. For 
each movement, sEMG signals were collected in three consecu-
tive repetitions of 4 s each, in which each repetition was followed 
by 4 s of rest. The subjects were asked to execute the movements 
at approximately 70% of their maximal voluntary contraction 
(according to their subjective estimation) to prevent premature 
fatigue. Before proceeding with the actual data collection, each 
subject executed one preparatory recording session to become 
familiar with the system. The recordings are available online 
in the repository of bioelectric signals of BioPatRec, under the 
name 8mov16chLowerLimb (27).
Signal Treatment
Data recorded during the contraction time usually contain absent 
or transient sEMG signals due to a delay between the movement 
prompt and the actual execution, or anticipatory relaxation of the 
muscles. We reduced the impact of ambiguous information by 
discarding 15% of the signal at the beginning and at the end of 
the contraction time. This yielded trimmed contraction periods 
of 2.8 s each, which were then concatenated resulting in 8.4 s of 
total contraction signal. The signal obtained was subsequently 
divided, or segmented, into time windows of 200 ms, with 50 ms 
time increment. The segmentation produced 163 time windows 
for each movement, and from each time window four sEMG 
signal features were extracted per channel (mean absolute value, 
wave length, slope changes, and zero crossings) (28). The features 
extracted from all channels in a given time window formed a 
feature vector. The 163 features vectors corresponding to each 
time window were then randomly assigned to the classifiers’ 
training, validation, and testing sets in the following respective 
proportions: 40, 20, and 40% (25).
Classifier Training and Real-time Evaluation
The “rest” condition was considered as a movement or class, result-
ing in a classification task of nine patterns. Linear Discriminant 
Analysis in a One-Vs-One topology (LDA-OVO) was used for 
classification (5, 6). Immediately after the classifier was trained, 
the real-time performance in each electrode configuration was 
evaluated with the Motion Test (29), as it is implemented in 
BioPatRec (25). The Motion Test asks subjects to execute the 
trained movements that are presented to the user in random 
order Subjects performed the test twice. The following metrics 
were then evaluated:
•	 Selection time: time elapsed between the first prediction differ-
ent from rest and the first correct prediction. The shortest selec-
tion time possible was 211 ms (200 ms of the first time window 
plus the processing time before the prediction is available).
FigUre 2 | Photographs depicting the trained motions (a) knee extension and flexion, (B) femoral rotation outwards and inwards, (c) ankle plantar flexion  
and dorsiflexion, and (D) and tibial rotation outwards and inwards.
4
Lendaro et al. PME for Lower Limb PLP
Frontiers in Neurology | www.frontiersin.org September 2017 | Volume 8 | Article 470
FigUre 3 | Representation of the phantom limb pain location in the 
lower-limb amputee subject treated with phantom motor execution.
FigUre 4 | Example of targeted monopolar configuration used for the 
phantom motor execution treatment of the patient with lower-limb 
amputation.
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•	 Completion time: time elapsed between the first prediction dif-
ferent from rest (as in the selection time) and the 20th correct 
prediction. The shortest completion time possible was 1.16 s.
•	 Completion percentage: the percentage of motions that were 
completed; or the motions that reached 20 correct predictions 
before the 10 s timeout.
•	 Real-time accuracy: only calculated for completed motions and 
accounts for the number of predictions needed to obtain 20 
correct predictions. For example, if the completion time took 
25 time windows, the real-time accuracy would be 80%.
The order in which Motion Tests were performed was rand-
omized within the TBC and TMC groups. Two conditions were 
evaluated in random order with the UMC session: all 16 channels; 
and a subset of equally spaced 8 channels.
Statistical Analysis
We investigated the real-time performance of two alternative 
electrode configurations (TMC and UMC) to the conventional, 
TBC. Testing for statistical significance was conducted only on 
the non-amputees owing to the small sample size of the amputee 
group, in which case-only descriptive statistics were used. The 
TBC and TMC configurations were investigated on the same 
subjects, and the classifier for the real-time classification task 
was trained using data collected within the same recording ses-
sion. Consequently, the two groups were compared by using the 
Wilcoxon signed-rank test. The UMC configuration was analyzed 
on a different set of subjects. The comparison between TBC and 
UMC with 8 channels (UMC-8 ch), and the one between UMC-8 
ch and TMC were performed with Wilcoxon rank sum test for 
independent samples. In addition, UMC was investigated in 
two variants, with 8 and 16 channels, to determine if additional 
channels could improve performance, as tested with Wilcoxon 
signed-rank. Statistical significance was considered at p <  0.05 
with Bonferroni correction.
Part ii: case study on a PlP sufferer
The Subject
A 70-year-old male with traumatic transfemoral amputation 
(unilateral) took part in the pain treatment case study. The 
subject described his phantom leg as of the same length as his 
normal leg and located the phantom pain in the foot (Figure 3, 
location 5). The PLP had been present since the amputation 
35 years ago. However, the overall pain intensity had increased 
over the years, despite the implantation of a spinal cord neuro-
stimulator 10 years prior to the start of our investigation. The 
participant described the pain as sustained low intensity pain, 
mainly present during the day, and recurrent high intensity pain, 
predominant in the evenings and at night. During periods of 
strong pain, the subject would feel the need to stand up, walk 
around, and use the neurostimulator. As a result, his sleep was 
disturbed by pain seizures that would wake him up and make 
him unable to sleep for more than 2 h per night.
The PME Treatment
The patient received PME interventions twice per week, for a total 
of 23 sessions. Each session lasted approximately 2  h, starting 
with pain assessment and continuing with PME. PLP was also 
monitored at 1, 3, and 6 months after the last treatment session.
After the pain interview, electrodes were placed on the stump. 
Initially the treatment was conducted with 16 electrodes in the 
TMC configuration (see Part I: Classification of Non-Weight-
Bearing Lower-Limb Movements). However, after few treatment 
sessions, the muscles of the stump increased in size, producing 
stronger signals. Consequently, the electrodes were gradually 
reduced to eight (the subject preserved his ability to control 
the virtual environments). The location of the electrodes was 
determined by palpation while requesting the patient to move his 
phantom leg. Figure 4 shows an example of the TMC configura-
tion used.
TaBle 1 | Performance metric mean values (SE) for each configuration: targeted monopolar configuration (TMC), targeted bipolar configuration (TBC), untargeted 
monopolar configuration with 8 channels (UMC-8 ch), and untargeted monopolar configuration with 16 channels (UMC-16 ch).
Performance metric TMc TBc UMc-8 ch UMc-16 ch
amputee 
(n = 2)
healthy 
(n = 6)
amputee 
(n = 2)
healthy 
(n = 6)
amputee 
(n = 2)
healthy 
(n = 6)
amputee 
(n = 2)
healthy (n = 6)
Completion rate % 75.0 (4.2) 79.8 (2.1) 80.2 (7.3) 83.7 (5.3) 79.1 (16.6) 91.3 (4.1) 69.8 (13.5) 87.5 (6.0)
Real-time accuracy % 81.7 (6.1) 81.5 (3.0) 86.9 (1.6) 84.6 (2.9) 86.0 (1.6) 84.7 (2.3) 83.9 (2.3) 81.4 (1.1)
Completion times 5.15 (0.35) 5.15 (0.12) 4.75 (0.13) 4.95 (0.12) 4.86 (0.14) 4.88 (0.08) 4.91 (0.12) 5.13 (0.05)
Selection times 0.84 (0.21) 0.77 (0.05) 0.59 (0.14) 0.72 (0.12) 0.83 (0.38) 0.69 (0.10) 1.25 (0.49) 0.88 (0.05)
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Different phantom movements (or set of movements) were 
exercised at an increasing level of difficulty as done in the upper 
limbs [see appendix of Ortiz-Catalan et  al. (4) for details]. 
Myoelectric signals associated with the chosen set of movements 
were recorded to train the MPR system with LDA-OVO topol-
ogy. The patient then practiced PME in virtual reality (VR), to 
later perform target achievement control (TAC) tests (30). The 
TAC test consists of executing the trained motions to control 
a virtual limb to match random target postures presented on 
the screen. The target postures reflected the previously trained 
1 degree-of-freedom movements, as well as combinations of 
these to achieve multiple degrees of limb motions. The level 
of difficulty of the exercise depended on the number of move-
ments trained, the type of movement, and if these were executed 
simultaneously. For example, distal movements are generally 
harder to control. On the other hand, consistent with our 
working hypothesis that PME reverts the central and peripheral 
maladaptive changes that took place following amputation, we 
aimed at exercising movements of the part of the phantom limb 
perceived as painful, which is commonly distal, as in the case 
of this patient.
Pain Assessment
The pain assessment interview was conducted at the beginning 
of each session and at 1, 3, and 6 months after the end of the 
treatment. We assessed changes in intensity, quality, and dura-
tion of PLP with a questionnaire derived from the Swedish 
version of the Short Form of the McGill Pain Questionnaire 
(SF-MPQ) (31) and study-specific questions. Specifically, the 
Numeric Rating Scale from 0 (no pain) to 10 (worst possible 
pain) was used to evaluate the intensity of pain at the moment 
of the interview. Moreover, quality and intensity of pain was 
assessed by the Pain Rating Index (PRI), as per SF-MPQ (32), 
and was calculated as the sum of the individual scores given 
to the pain descriptors. Furthermore, the time-varying pain 
profile of an average day was captured by a study-specific 
metric, the weighted pain distribution (WPD) (4–6), which 
required the patient to estimate the percentage of the time 
awake spent at each level of a 6-point scale (none to maximum, 
0–5). The results of the questionnaire were then summarized 
in the WPD, which is the weighted sum of the pain scores. PLP 
location and length of the phantom limb were also monitored 
at each session. Finally, the patient was free to self-report com-
ments regarding any aspect of the treatment, pain perception 
and quality of life.
resUlTs
Part i
Table 1 shows the results of the real-time tests as mean values 
and related SEs. For non-amputees, the real-time performance 
metrics and the offline accuracy are also presented in boxplots. In 
addition, data points representing the mean over the motions for 
amputees and non-amputees are plotted on top of the boxplots, 
and the pairs of the dependent samples are connected by lines 
(Figure  5). Finally, Figure  6 shows the cumulative completion 
rate for both non-amputees and amputees, which represents the 
percentage of motions completed as a function of time.
The statistical testing for the comparison of TMC to TBC did 
not reveal any significant differences in the metrics for evaluating 
the performance in real time (completion percentage: p = 0.37; 
selection time: p = 0.43; real-time accuracy: p = 0.31; completion 
time: p = 0.43) or offline (offline accuracy: p = 0.68). Nevertheless, 
TBC performed better in the majority of the cases when consider-
ing the pairs between the two samples (data points connected 
by lines). A larger sample size could have likely revealed a signifi-
cant difference.
In comparing UMC (eight channels) to TBC, a significant 
effect was found for the completion percentage (p = 0.002), while 
the remaining metrics presented no significant differences (selec-
tion time: p = 1; real-time accuracy: p = 0.81; completion time: 
p = 0.58; offline accuracy: p = 0.73). Similarly, the comparison 
between UMC and TMC yielded a significant difference in the 
completion percentage (p = 0.002), but not in the other metrics 
(selection time: p = 0.39; real-time accuracy: p = 0.13; completion 
time: p = 0.13; offline accuracy: p = 0.48).
Finally, the investigation conducted of UMC revealed that 16 
channels did not have any improvement over the performance 
of the electrode configuration with just 8 channels, and no sig-
nificant differences were found (completion percentage: p = 0.56; 
selection time: p = 0.56; offline accuracy: p = 0.68), even though 
real-time accuracy and completion time were better with 8 
channels, as seen from the low p-value and the pairwise visual 
inspection in Figure 6 (real-time accuracy: p = 0.03; completion 
time: p = 0.03).
Part ii
The interventions took place between January 28, 2016 and April 
19, 2016. The patient was initially able to control proximal move-
ments (knee flexion/extension, hip rotation medial/lateral) in 
only 1 degree of freedom. By the end of the treatment, the patient 
FigUre 5 | Box plots presenting the results of the comparison of the three electrode configurations in terms of real-time metrics relative [i.e., (a) completion 
percentage, (B) completion time, (c) selection time, (D) real-time accuracy] and (e) offline accuracy. The boxplots represent only the data relative to non-amputated 
subjects. The line in the center of the boxes indicates the location of the median, the upper edge indicates the third quartile, the bottom edge represents the first 
quartile, and the whiskers indicate the data range. Along with every boxplot, it is possible to the mean value for each subject. Red dots represent non-amputees, 
while the square and a star marker represent the data points for the transtibial and the transfemoral amputee subject, respectively. Statistical significance (p < 0.05) 
is marked by the *.
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had acquired control over the entire lower limb, including toes, 
and was able to exercise up to 4 degrees of freedom within the 
same session (Video S1 in Supplementary Material). Between 
the first and the last treatment session, an overall reduction 
of PLP intensity was measured by all metrics. PLP intensity 
decreased by 2 points on the NRS scale (from 4 to 2, 50%) and 
by 22 points in PRI (32 to 10, 68%) (Figure 7). A positive change 
was also reported in the time-varying profile of PLP, in which 
the WPD decreased by 1.8 points (from 3.2 to 1.4, 57%) by the 
last treatment session (Figure 8). The progress in pain reduc-
tion, presented as distribution of pain over time, is presented in 
Figure 9, and the estimated time slept is presented in Figure 10. 
In particular, the higher-intensity PLP (pain levels of 4 and 5), 
usually present in the evening and at night, reduced consider-
ably over time. This was accompanied by an increase in length 
and quality of sleep from 2  h per night with interruptions to 
7 h without interruptions. The pain location remained constant 
throughout the entire treatment period (in the foot), and the 
phantom limb maintained the same dimensions it had at the 
beginning of the treatment, thus being of the same length as 
the normal leg. The patient noted an improvement in quality 
of life since the start of the treatment, with less tiredness, 
improved mood, and regained ability to drive for long distances 
(>200 km at a time, which was not possible before). Moreover, 
both family and patient observed a reduction in the use of the 
neurostimulator during the day.
From Figures  7–10, it is also possible to see the profile of 
PLP after the end of the treatment, as recorded at the follow-
up interviews 1, 3, and 6  months after. The positive effects of 
the treatment were retained at the first and second follow-up 
interviews but had almost vanished by the sixth month.
DiscUssiOn
The aim of this study was twofold. First, we wanted to investigate 
the performance of two alternative electrode configurations to 
conventional bipolar targeted recordings in terms of real-time 
metrics. Second, we evaluated PME as a treatment of PLP on 
lower-limb amputations in a chronic intractable case.
In the first part of this article, we showed that classification is 
possible similarly in all of the three configurations. Looking at the 
comparison between TMC and TBC in the boxplots of Figure 5, 
the latter performed better in most cases. A possible explanation 
of this result is that the distance between the electrodes, and the 
FigUre 6 | Cumulative completion rate for (a) non-amputated and  
(B) amputated subjects.
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CCE in TMC, is generally larger than the inter-electrode distance 
for TBC. This could result in an increase of crosstalk picked up 
by the electrodes and CCE, yielding lower SNR, as our previous 
study showed (23). Conversely, the distance between the elec-
trodes and the CCE in the UMC was reduced, possibly rendering 
fewer disturbances in the signals, thereby explaining the better 
performance.
It is worth noticing that the UMC with 16 channels did not 
outperform the same configuration with just 8 channels. On the 
contrary, it might appear that, when considering real-time accuracy 
and completion time, fewer channels improved the performance.
Besides real-time performance of the classifier, there are 
secondary factors that can be taken into account to determine 
which electrode placement method should be preferred for a 
clinical application. First, TBC might not be an option when 
dealing with patients with short stumps, as not all the muscles 
required for targeted configurations might be available. Second, 
the targeted electrode placement can be difficult and time 
consuming because of the difficulty of identifying the correct 
muscles, due to excessive soft tissue, weakness, or muscle 
relocation, even when the muscles are available. Third, the use 
of bipolar electrodes requires parallel alignment to the muscle 
fibers for optimal recordings (33), as well as avoiding innerva-
tion zones (34). Parallel alignment in differential measurements 
is recommended because this is the direction of the propagation 
of the action potential. However, this alignment is difficult to 
achieve in muscle fibers forming a pennation angle (such as the 
quadriceps). Altogether, sEMG signal acquisition in the lower 
limbs could be facilitated by placing the electrodes in monopo-
lar configurations (UMC and TMC). This configuration is 
insensitive to the fiber orientation and position of the electrode, 
with respect to the innervation zone. Moreover, we show that 
it is not necessary to target  all the superficial muscles of the 
thigh, even when available. UMC yielded real-time classification 
accuracy comparable to the targeted configurations (TMC and 
TBC). However, optimizing the targeted electrode placement by 
identifying the active areas of the stump muscles can improve 
the quality of the MPR in amputee subjects.
Altogether, UMC or TMC, with CCE made of conductive 
fabric, was beneficial for implementing a rehabilitation system. 
In addition to faster and easier electrode placement, such con-
figurations also need only half the pre-gelled adhesive electrodes 
normally used in a bipolar configuration. This means an economic 
advantage, in addition to reducing material waste.
Moreover, the use of the CCE of conductive fabric opens pos-
sibilities for developing solutions made entirely of wearable smart 
textiles, which would allow patients to easily take them on and off. 
In addition, a textile solution could be reused and easily be adapted 
for different anatomies without changes in the design (35).
The second part of the paper was dedicated to evaluating 
PME as a strategy to treat PLP in a subject with lower-limb 
amputation. In accordance with previous studies on upper 
limbs (4–6), improvement was found in all the metrics used for 
pain evaluation following treatment by PME. Conversely, PLP 
was not eliminated completely, despite the fact that the inter-
vention took place over a longer period of time and follow-up 
interviews revealed that the positive effects almost vanished 
within 6 months, as opposed to what was demonstrated in the 
previous clinical trial. Overall, this might indicate that more 
sessions are required in case of PLP in the lower extremities, or 
that the contribution of augmented reality could induce more 
rapid, longer-lasting changes.
Nevertheless, we showed that the realistic visual feedback 
induced by augmented reality was not essential to obtain pain 
reduction via PME treatment, raising doubts as to whether or 
not, a more realistic visual illusion concerning the virtual limb is 
necessary to mediate the perception of PLP. Our work and others 
suggest a relationship between the ability to control movements 
of the phantom limb and PLP, and therefore we cannot exclude 
that pain relief could be achieved just by training phantom mobil-
ity without appropriate visual feedback. Our previous studies, 
together with the current one, are limited in this sense due to the 
lack of an appropriate control group, and additional investiga-
tions aimed at unveiling these aspects are required.
Although not quantified, we observed morphological changes 
in the stump related to regained muscular mass. These changes 
were accompanied by improvement in voluntary control of the 
phantom limb, also not recorded by any direct measure, but 
FigUre 8 | Graph representing the value of the Weighted Pain Distribution (WPD) throughout the 23 treatment sessions and at 1, 3 and 6-month follow-up (right 
hand side of the dashed line). The WPD is calculated as the sum of the scores (0–5) weighted on the total time spent awake.
FigUre 7 | Evolution of the Pain Rating Index (PRI) over the course of the treatment and in the follow-up period (6 months). The PRI is calculated as the sum of the 
scores (0–5) assigned to the pain descriptors of the Short Form of the McGill Pain Questionnaire (SF-MPQ). The SF-MPQ was administered at the beginning of each 
treatment session twice per week (left hand side of the dashed line) and at 1, 3, and 6-month follow-up (right hand side of the dashed line).
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clearly indicated by the ability to control an increasing number 
of degrees of freedom of the virtual limb. It is possible that 
structural alteration of the stump was accompanied by functional 
and neurophysiological variations, accounting for the effects 
that we observed on PLP. In the future, studies should quantify 
morphological changes in the stump, improvements in phantom 
motor control, alteration of sensorimotor cortical maps, and how 
these relate to PLP.
Finally, the use of a CCE for monopolar recording may allow 
for faster electrode placement, which means that more time can 
FigUre 10 | Time slept as estimated by the subject over the course of the treatment and during the follow-up period.
FigUre 9 | Weighted pain distribution (WPD) bar graph. Each bar represents a treatment session or a follow-up interview. The pain rating is from 0 to 5 where 5 
(red) is the worst possible pain.
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be spent in the treatment rather than in the setup. Moreover, 
using the monopolar configuration also implies that roughly 200 
Ag/AgCl pre-gelled electrodes were spared in this particular case 
study.
cOnclUsiOn
In the first part of this work, we demonstrate the possibility to 
use different techniques to acquire sEMG signals suitable for 
successful MPR of lower-limb movements in non-weight-bearing 
conditions. We concluded that monopolar recordings, enabled 
by a single differential electrode around the leg, seem a viable 
solution for a rehabilitative application. Future work will focus on 
further development of the system to make it more user-friendly.
In the second part, we investigated the efficacy PME in 
reducing chronic, intractable PLP on a subject with lower-limb 
amputation. The results were limited to one subject but were posi-
tive and put forward the need to investigate in a wider population 
to determine if PME, facilitated by MPR and VR, can effectively 
reduce PLP in the lower limb.
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In conclusion, the results of this research give us grounds 
to continue the work on our long-term goal of implementing a 
system for treating PLP based on PME for subjects with both 
upper- and lower-limb amputations.
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AbstrACt
Introduction Phantom limb pain (PLP) is a chronic 
condition that can greatly diminish quality of life. Control 
over the phantom limb and exercise of such control have 
been hypothesised to reverse maladaptive brain changes 
correlated to PLP. Preliminary investigations have shown 
that decoding motor volition using myoelectric pattern 
recognition, while providing real-time feedback via virtual 
and augmented reality (VR-AR), facilitates phantom motor 
execution (PME) and reduces PLP. Here we present the 
study protocol for an international (seven countries), 
multicentre (nine clinics), double-blind, randomised 
controlled clinical trial to assess the effectiveness of PME 
in alleviating PLP.
Methods and analysis Sixty-seven subjects suffering 
from PLP in upper or lower limbs are randomly assigned 
to PME or phantom motor imagery (PMI) interventions. 
Subjects allocated to either treatment receive 15 
interventions and are exposed to the same VR-AR 
environments using the same device. The only difference 
between interventions is whether phantom movements 
are actually performed (PME) or just imagined (PMI). 
Complete evaluations are conducted at baseline and at 
intervention completion, as well as 1, 3 and 6 months 
later using an intention-to-treat (ITT) approach. Changes 
in PLP measured using the Pain Rating Index between the 
first and last session are the primary measure of efficacy. 
Secondary outcomes include: frequency, duration, quality 
of pain, intrusion of pain in activities of daily living and 
sleep, disability associated to pain, pain self-efficacy, 
frequency of depressed mood, presence of catastrophising 
thinking, health-related quality of life and clinically 
significant change as patient’s own impression. Follow-
up interviews are conducted up to 6 months after the 
treatment.
Ethics and dissemination The study is performed in 
agreement with the Declaration of Helsinki and under 
approval by the governing ethical committees of each 
participating clinic. The results will be published according 
to the Consolidated Standards of Reporting Trials 
guidelines in a peer-reviewed journal.
trial registration number NCT03112928; Pre-results.
IntroduCtIon  
Phantom limb pain (PLP) is a chronic condi-
tion commonly suffered by amputees.1 2 
Although more than 60 different treatments 
to alleviate PLP have been described in the 
literature,3 controlled clinical trials on such 
treatments are scarce and tend to be of poor 
quality.4 The clinical investigation presented 
in this protocol aims to evaluate the effi-
cacy of phantom motor execution (PME) 
in reducing PLP in an international, multi-
centre, double-blind, randomised controlled 
clinical (RCT) trial. PME is accomplished by 
using a system (Neuromotus, Integrum AB, 
Sweden) that employs myoelectric pattern 
recognition to predict motor volition (move-
ments of the phantom limb) while providing 
real-time feedback to the patient in virtual and 
augmented reality (VR/AR) environments. 
strengths and limitations of this study
 ► This study involves a   suitable number of partic-
ipants (>60) to provide the power necessary for 
meaningful conclusions. 
 ► This study is double-blinded, randomised  con-
trolled clinical trial, conducted in geographically 
different locations and involves subjects with both 
upper and lower limb amputations, thus enhancing 
generalisability.
 ► The choice of the comparator allows controlling in a 
stringent manner for the effect of the key factor hy-
pothesised as the cause of pain reduction, namely, 
the execution of phantom limb movements.
 ► Treatment is limited to 15 sessions, which might not 
be enough to alleviate pain in all participants.
 ► The nature of the experimental treatment (phantom 
motor execution) does not allow inclusion of indi-
viduals from which myoelectric signals cannot be 
recorded from the muscles in their residual limbs.
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This technology allows the application of serious gaming 
in the therapy. PME is a non-invasive, non-pharmaco-
logical and engaging treatment with no identified side 
effects at present.5 6 
The effectiveness of PME was initially explored in 
a single upper limb amputee, with satisfactory results 
reported.5 Prior to the pilot study, the patient had shown 
resistance to a variety of treatments for 48 years (including 
mirror therapy). After PME, the sustained level of pain 
reported by the patient was gradually reduced to pain-
free periods. He and his family also reported less intru-
sion of PLP in sleep and activities of daily living (ADLs). 
Finally, the patient also acquired the ability to freely move 
his phantom arm and hand, consistent with a recent study 
by Raffin and colleagues7 where they found that reduced 
capability of phantom movement was correlated with 
more severe PLP.
In the light of the findings in the case study, a non-ran-
domised clinical investigation on PME was conducted in 
subjects with chronic intractable upper limb PLP.6 Four-
teen patients, for whom conventional PLP treatments 
failed and who suffered from PLP for an average of 10 
years, received 12 treatment sessions of PME, each of 
1.5-hour duration. At the end of the treatment period, 
patients showed statistically and clinically significant 
improvements (approximately 50% reduction of PLP). 
Intrusion of PLP during sleep and ADL was also reduced 
by a similar degree. These improvements were still 
present up to 6 months’ post-treatment.6 More recently, 
PME was also demonstrated to be a viable treatment for 
PLP in lower limb amputations.8
Strong evidence shows that PLP is related to neuro-
plastic changes in the primary somatosensory cortex, 
suggesting that central maladaptive plasticity is 
responsible for its maintenance. Neuroplasticity-based 
approaches for the relief of PLP, such as motor imagery 
and mirror therapy, ultimately aim to regain brain 
circuitry from pain processing. Nonetheless, these 
approaches have been shown to be limited in their 
effectiveness.
Although the practice of motor imagery has been shown 
to normalise previously altered cortical maps and reduce 
PLP,9 evidence from randomised clinical studies has also 
suggested that it can increase pain.10 These seemingly 
contradictory findings suggest that motor imagery should 
not be used alone but combined with other interventions, 
such as graded motor imagery11 or mirror therapy.12
Mirror therapy has demonstrated higher effectiveness 
than motor imagery in reducing pain10; however, it still 
cannot ensure that the patient performs movements 
with the phantom limb. For instance, it is enough for 
the patient to move their healthy arm to produce move-
ment in the reflected limb. Whether a patient is actually 
engaging in execution of phantom limb movements is 
unknown. PME overcomes some of the methodolog-
ical limitations of previous treatments by ensuring that 
central and peripheral mechanisms in motor control are 
activated during therapy.
study objECtIvE
This paper presents the study protocol for a RCT in which 
upper and lower limb amputees are treated. The inves-
tigation primarily aims at assessing the efficacy of PME 
aided by myoelectric pattern recognition, VR/AR and 
serious gaming to reduce PLP. In order to isolate the 
contribution of PME in alleviating PLP over potential 
placebo effects, phantom motor imagery (PMI) is used in 
this study as an active control treatment.
The working hypothesis of PME is that execution of 
phantom limb movements would exploit competitive 
neuroplasticity and provide a more integral normalisation 
of cortical, subcortical and spinal circuits compared with 
interventions that do not enable integration of sensory 
and motor information. Therefore, in this superiority 
trial, we hypothesise that the participants receiving the 
experimental treatment (PME) to obtain a larger reduc-
tion in PLP levels than those randomised to the control 
treatment.
trIAl dEsIgn
This clinical study is an international, multicentre, double-
blind, randomised controlled trial. The study takes place 
in seven counties and involves nine clinics, which are listed 
in table 1. Participants are randomly assigned to receive 
either the experimental or the control treatment in a 2:1 
allocation ratio. The choice of the allocation ration was 
made in order to collect more data on the intervention 
of interest. Each patient is followed up for a period of 
6 months, at the end of which they are given the choice to 
undergo the alternative treatment. The total duration of 
the study is expected to be approximately 3 years.
Table 1 List of the investigational sites, divided by 
countries taking part to the international, multicentre 
randomised clinical trial
Country Investigational site
Sweden Sahlgrenska University Hospital, Gothenburg
Örebro University Hospital, Örebro
Rehabcenter Sfären, Bräcke Diakoni, 
Stockholm
Slovenia University Rehabilitation Institute, Ljubljana
Belgium Fysische Geneeskunde en Revalidatie 
University Hospital Gent, Gent
The 
Netherlands
Department of Rehabilitation Medicine, 
University Medical Centre Groningen, 
Groningen
Canada Institute of Biomedical Engineering, University 
of New Brunswick, New Brunswick
Ireland Centre for Pain Research, National University 
of Ireland, Galway
Germany Department of Psychosomatic Medicine and 
Psychotherapy, LWL University Hospital, 
Ruhr-University Bochum, Bochum
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MEthods: pArtICIpAnts, IntErvEntIons, And outCoMEs
A procedural overview of the trial is provided by the flow 
diagram of figure 1. Recruitment of the participants 
is conducted via advertisements at local investigation 
clinics, on social media and in local newspapers. People 
who are interested in taking part in the trial are invited to 
contact the principal investigator of the site, or a person 
appointed by the principal investigator, via phone or 
email.
Eligibility criteria
Interested people are invited to a preassessment visit (visit 
0). On this occasion, the therapist (clinical investigator) 
explains the study in detail and answers all the questions 
that might arise. Afterwards, the participants are asked 
to provide written informed consent (see supplementary 
appendix A). If consent is granted, eligibility to the study 
is assessed according to the criteria presented below:
 ► The participants must be older than 18 years with 
chronic PLP.
 ► Participants must have chronic PLP—at least 6 months 
should have passed since amputation. Participants 
with acute PLP are non-eligible.
 ► In case of pharmacological treatments, the dosage 
must have been stable for the previous month.
 ► Any previous PLP treatments must have terminated at 
least 3 months prior to entering the study.
 ► Any pain reduction potentially attributable to previous 
PLP treatments must have occurred at least 3 months 
prior to entering the study.
 ► Voluntary control over at least a portion of biceps 
and triceps muscles in case of upper limb amputation 
or quadriceps and hamstrings in case of lower limb 
amputation.
 ► Stable prosthetic situation (ie, satisfaction with the 
fitting of the prosthesis) or being a non-user.
Figure 1 Flow diagram for the randomised controlled clinical trial. At least 67 patients are recruited and randomly allocated 
to either phantom motor execution (PME) or phantom motor imagery (PMI) interventions in allocation ratio 2:1. Following the 
completion of the treatment protocol and wash-out period of 6 months, it is possible for the patient to cross over to the parallel 
interventional arm, according to their will.
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 ► The subject should not have a cognitive impairment 
that prevents them from following instructions.
 ► No abundant soft tissue on the stump that prevents 
sufficient myoelectric signals from being recorded.
 ► No presence of pain >2 on Numerical Rating Scale 
(NRS) on contact with the skin or muscle contraction 
in the stump.
 ► The PLP must not be aggravated (NRS >4) by the 
execution or imagination of phantom movements.
 ► No condition associated with risk of poor protocol 
compliance.
 ► No injury, disease or addiction that would render the 
individual unsuitable for the trial.
 ► Pain Rating Index (PRI) >0 as assessed in the Ques-
tionnaire for Phantom Limb Pain (Q-PLP) at visit 0.
Concomitant medications
Any cointervention aiming to reduce PLP is prohibited 
during the trial. However, in the design of the trial, it is 
acknowledged that there is a large possibility for patients 
with PLP to be high consumers of analgesic medicines. 
Therefore, the use of concomitant medications is allowed 
provided that at the time of inclusion, the patient has 
stable consumption for at least 1 month before entering 
the study and any pain reduction potentially attributable 
to the drug occurred at least 3 months before entering 
the study. Intake of pain medication in patients who show 
considerable improvement can be gradually reduced at 
the discretion of the responsible physician, given that 
the patient is followed up regularly. Medication intake is 
thus monitored as an outcome variable called ‘need of 
concomitant medication’, which is used to describe and 
compare the amount of comedication in the treatment 
groups.
Interventions
All of the therapists at the clinics are introduced to the 
technology with at least one practical demonstration by 
the first (EL) and/or last author (MO-C). The therapists 
conduct the interventions independently, and periodi-
cally the first author monitors the correct execution of the 
protocol. Participants in both intervention groups receive 
15 treatment sessions of 2 hours’ duration, including 
system setup and a blinded outcome assessment. The 
frequency of the sessions is chosen by the participant 
and can be once, twice (advised frequency) or five times 
per week, yielding a total patient duration that ranges 
between 28 and 40 weeks. Both treatment groups use the 
same device and setup, which are sketched in figure 2. 
The only difference between the two groups is the type of 
interaction with the virtual environments (active: motor 
execution; or passive: motor imagery). Allocated inter-
ventions for a given trial participant cannot be modified. 
Dates of the treatment sessions are recorded.
Experimental treatment
In the PME intervention, motor volition is decoded by 
interpreting the signals from the stump muscles via 
myoelectric pattern recognition.13 14 The decoded move-
ment is visualised in the virtual environments (ie, virtual 
limb or serious gaming). The end result is that the user, 
by training with the system, can achieve control over the 
virtual environments by performing phantom limb move-
ments associated with kinetic sensations analogous to the 
ones pertaining to the limb prior to amputation.
A treatment session consists of the following steps:
1. Placement of the electrodes and fiducial marker.
2. Treatment cycles
a. Recording session.
b. Practice of PME with VR/AR.
c. Serious gaming using phantom movements.
d. Practice of PME by matching random target pos-
tures of a virtual arm in VR (TAC Test15).
3. Pain evaluation (Q-PLP; see Outcomes section).
Different treatment cycles (step 2) are repeated during 
a treatment session in order to execute various phantom 
limb movements or combinations of movements. The level 
of difficulty gradually increases during the treatment phase 
from 1 to 5 by adding df to be trained within the same treat-
ment cycle. In this context, a df is any pair of movements 
performing opposite actions such as opening and closing of 
the hand or extension and flexion of the knee.
Clinicians are instructed to advance the level of diffi-
culty once the previous level is accomplished success-
fully and revert to the previous level if the patient shows 
considerable difficulty accomplishing the tasks. More 
details on the acquisition of myoelectric signals, predic-
tion of motor volition, the various parts of the treatment 
session and the different levels of difficulty are presented 
in online supplementary appendix B.
Control treatment
In the control treatment (PMI), patients are not allowed 
to produce/execute phantom movements, but must 
imagine performing such movements while observing them 
Figure 2 Schematic illustration of the clinical investigation 
device with all its components. Myoelectric signals are 
acquired though surface electrodes (A) by a myoelectric 
amplifier (B), electrically isolated (C). The signals are then 
processed by the software installed on the computer (D). The 
camera (E) films the participant and the recorded image is 
displayed on the monitor (F) with a virtual limb superimposed 
where the marker (G) is detected. Figure courtesy of Jason 
Millenaar.
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executed autonomously by the VR/AR environments. The 
device is identical to the one used in the experimental treat-
ment, but here the myoelectric signals are used to monitor 
that the patient does not produce muscular contractions, 
rather than decoding motor volition.
The control treatment session is conducted using the 
same stepwise procedure as the experimental group 
with the addition of a calibration step at the beginning 
of the treatment cycle. Calibration is necessary to set the 
threshold for myoelectric signals above, which the system 
alerts the user that a muscular contraction is performed. 
As in PME, the treatment cycle is repeated for different 
imaginary phantom limb movements or a set of imaginary 
movements following the same levels of difficulty. In the 
game format, the participants control the game using the 
keyboard with an able limb. Bilateral upper limb amputees 
use a joystick with any able limb. Details on the methods 
are presented in online supplementary appendix B.
Withdrawal or termination of individual participants
Participants are free to withdraw from participation in the 
study at any time on request. An investigator may termi-
nate participation in the study if:
 ► Any clinical adverse event, clinical abnormality or 
other medical condition or situation occurs such that 
continued participation in the study would not be in 
the best interest of the participant.
 ► The participant no longer meets the eligibility criteria 
because of a condition newly developed or not previ-
ously recognised.
The main analysis will be conducted using the inten-
tion-to-treat (ITT) methodology. Missing data due to 
withdrawal or termination will be imputed using the ‘last 
observation carried forward’ method. From previous 
studies, the dropout rate is estimated at approximately 
10%, and this was taken into account for the calculation 
of the sample size.
outcomes
Outcomes will be evaluated at every treatment session 
and three follow-up assessments at 1, 3 and 6 months’ 
post-treatment. The outcomes are measured by the 
evaluators following the participant treatment schedule 
presented in table 2.
Primary outcome measure
The primary outcome of the study is the change in PLP 
intensity measured by the difference in PRI between base-
line (visit 0) and at the post-treatment assessment (visit 
15). The PRI is computed as the sum of the scores for all 
descriptors of the Short Form of the McGill Pain Ques-
tionnaire (SF-MPQ).16 Within this study, the SF-MPQ is 
included in one more extensive survey named Question-
naire for Phantom Limb Pain, which is described below 
in the secondary outcome measures.
Secondary outcome measures
Secondary outcomes consider different aspects related 
to PLP such as pain frequency, pain duration, quality 
of pain, intrusion of pain in ADLs and sleep, disability 
associated with pain, pain self-efficacy, mood, presence 
of catastrophising thinking, health-related quality of life 
and the patient’s own impression about the effect of treat-
ment. The secondary outcome measures are:
Pain Disability Index (PDI)
PDI, a seven-item questionnaire designed to investi-
gate the extent to which chronic pain interferes with a 
person’s ability to engage in various life activities.17 An 
Table 2 Summary of the different items (intervention, forms 
and questionnaires) to be completed at each evaluation 
appointment
Session Summary of content
Visit 0  ► Patient information (T).
 ► Study consent (T).
 ► Preassessment (T).
 ► Background information (T).
 ► Q-PLP (T).
 ► PDI (T).
 ► EQ5D-5L (T).
 ► PSEQ-2 (T).
 ► PCS-SF (T).
 ► PHQ-2 (T).
 ► EXPECT-SF (T).
Randomisation
Visit 1  ► Treatment session (T).
 ► Q-PLP (E).
 ► OAT (E).
 ► EXPECT-SF (E).
 ► HCCQ-SF (E).
Visits 2–14  ► Treatment session (T).
 ► Q-PLP (E).
Visit 15  ► Treatment session (T).
 ► Q-PLP (E).
 ► PDI (E).
 ► EQ5D-5L (E).
 ► PSEQ-2 (E).
 ► PCS-SF (E).
 ► PHQ-2 (E).
 ► PGIC (E).
 ► HCCQ-SF (E).
1-month follow-up  ► Q-PLP (E).
 ► PDI (E).
 ► EQ5D-5L (E).
 ► PSEQ-2 (E).
 ► PCS-SF (E).
 ► PHQ-2 (E).
3-month follow-up
6-month follow-up
The letter in brackets indicates whether the therapist (T) or the 
evaluator (E) is responsible of conducting a particular item is
EQ-5D-5L, EuroQol-5D-5L; EXPECT-SF, Expectations for 
Complementary and Alternative Medicine Treatments Short Form; 
HCCQ, Health Care Climate Questionnaire; OAT, Opinion About 
Treatment; PCS-SF, Pain Catastrophizing Scale Short Form; PDI, 
Pain Disability Index; PGIC, Patients’ Global Impression of Change; 
PHQ-2, two-item Patient Health Questionnaire; PSEQ-2, two-
item Pain Self-Efficacy Questionnaire; Q-PLP, Questionnaire for 
Phantom Limb Pain. 
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overall PDI score is obtained by summing the numerical 
ratings of the questionnaire’s single items.
Questionnaire for Phantom Limb Pain
The Q-PLP is a 16-item questionnaire based on a combi-
nation of the SF-MPQ16 and study-specific questions use 
in previous studies.5 6 8. The part containing the SF-MPQ 
is used for the calculation of the PRI (primary outcome 
measure).
The Q-PLP assesses intensity, quality, duration and 
frequency of PLP using the following metrics: the 
numeric rating scale (scale range 0–10) to assess the 
intensity of pain at present; the weighted pain distribu-
tion (scale range 0–5) to capture the time-varying nature 
of chronic pain by adding the contributions of weighted 
portions of time spent in six pain levels (present pain 
intensity scale,18); and a study-specific descriptive scale of 
seven steps: ‘never’, ‘once per month’, ‘once per week’, 
‘few times per week’, ‘once per day’, ‘few times per day’ 
and ‘always’ to measure the frequency of pain.
In addition, the Q-PLP is used to monitor the inten-
sity of stump pain, phantom limb sensations, phantom 
motor ability, intrusion of PLP in ADLs and sleep, by one 
question each using a numeric rating scale. Changes in 
prosthetic hardware, medication, presence of telescoping 
(feeling that the phantom limb is gradually shortening 
over time) and location of pain are also monitored by the 
Q-PLP.
EuroQol-5D-5L (EQ-5D-5L)
The EQ-5D-5L is a standardised questionnaire used to 
investigate health-related quality of life, which is consti-
tuted by two components: health status and health 
evaluation.19 Health status is measured in terms of five 
dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression) on a five-point scale 
(no problems, slight problems, moderate problems, 
severe problems and extreme problems). In the health 
evaluation part, the EQ Visual Analogue Scale records 
the respondent’s health on a vertical VAS where the end 
points are labelled ‘best imaginable health state’ and 
‘worst imaginable health state’.
Pain Self-Efficacy Questionnaire (PSEQ-2)
The PSEQ-2 is a two-item questionnaire that measures pain 
self-efficacy, which is the belief held by people with chronic 
pain that they can carry out certain activities and enjoy life, 
despite experiencing pain.20 21 The items of the question-
naire are rated on a numeric rating scale from 0 to 6.
Pain Catastrophizing Scale – 6 (PCS-6)
The PCS-6 is a six-item questionnaire that investigates 
catastrophising thinking in a range from 0 to 4.22 23 
Pain catastrophising denotes a negative cognitive-affec-
tive response to pain and is associated to increased pain 
severity, disability and depressive symptoms and is associ-
ated with poor adjustment to chronic pain.24
Patient Health Questionnaire-2 (PHQ-2)
The PHQ-2 is a screening instrument consisting of two 
items assessing the presence of a depressed mood and a 
loss of interest or pleasure in routine activities.25 26 The 
items of the questionnaire are rated on a numerical scale 
from 0 to 3.
Patients’ Global Impression of Change (PGIC)
The PGIC is a single question used to identify clinically 
significant change by rating the patient’s belief about the 
efficacy of treatment on a seven-point scale, ranging from 
‘no change (or condition has got worse)’ to ‘a great deal 
better’.27
Additional measurements
Participants are asked to supply details regarding back-
ground information such as age, gender, height, weight, 
type and use of the prosthesis, level of embodiment of 
the prosthesis, onset of PLP, details about previous and 
ongoing intervention for PLP and side, level and date 
of amputation. Additionally, we also survey: patients’ 
expectancy of benefit using the Expectations for 
Complementary and Alternative Medicine Treatments 
(EXPECT-SF)28; patients’ judgement about the cred-
ibility of the treatment using the Opinion About Treat-
ment (OAT)29 and patients’ perception of therapists’ 
supportive behaviour using the short form of the six-item 
Health Care Climate Questionnaire (HCCQ).30
Sample size
The calculation of the sample size was based on our 
primary hypothesis and informed by our previous clin-
ical trial with no control group.6 In order to find a mean 
difference of 4 between the two randomised groups in 
the primary outcome measure (PRI), with power of 
80% resulting from a two-sided Fisher’s non-parametric 
permutation test at 5% significance level, is estimated that 
at least 60 participants are required. As a drop-out rate of 
10% is expected, a total of 67 patients will be randomised.
MEthods: AssIgnMEnt of IntErvEntIon
randomisation
Participants are assigned to the experimental or control 
group according to the optimal allocation scheme of 
minimisation, aimed at reducing the imbalance between 
the number of patients allocated to each treatment 
group. The randomisation proportion is 2:1, with twice 
as many subjects assigned to the experimental treatment. 
The allocation ratio was chosen to collect more informa-
tion on important variables regarding the intervention of 
interest. The allocation aims to minimise the imbalance 
of the following factors:
 ► Level of amputation (upper and lower).
 ► Baseline PLP based on the NRS (low 1–4, and high 
5–10).
 ► Investigation site (nine centres).
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The minimisation process is conducted using the open-
source desktop application MinimPy,31 operated by the 
monitor of the clinical trial. Every time a research team at a 
particular investigational site recruits a new participant, they 
assess the person’s eligibility for the study (visit 0). After-
wards, if the participant is deemed eligible, the research 
team sends the minimisation factors relative to the enrolled 
participant to the monitor, who runs the randomisation and 
informs the research team of the allocation.
blinding
This investigation has been designed in such a way that 
participants of the two treatment groups use the same 
device under the same circumstances.
Even though the patients are necessarily aware of the 
treatment they are receiving, they do not have an expec-
tation of superiority of the experimental over the control 
treatment (or vice versa), since the trial is framed as a 
comparison between two different interventions previ-
ously described in the literature. It is worth noting that 
the distinction between motor execution and motor 
imagery is often imperceptible, even for professionals 
in the field, who have often described voluntary move-
ments of the missing limb as imaginary movements.9 32–37 
We take this fact as a corroborant of our assumption 
that there are no differences at baseline with respect to 
expectations and opinions about the assigned treatment 
among participants. Nevertheless, individuals’ expecta-
tions regarding outcomes and credibility of the assigned 
treatment are assessed with the EXPECT-SF and the OAT 
questionnaires, respectively.
The nature of the investigation does not allow the 
masking of the treatment for the therapists. However, it is 
still important to check for possible differences between the 
two groups concerning the therapists’ supportive behaviour. 
For this reason, the HCCQ, is included as a measure of the 
extent to which a healthcare provider (or the staff) interacts 
with their patient in a supportive manner.
The outcome assessments are conducted by indepen-
dent persons who are blinded to the group allocation, 
making the trial double blind. In order to keep group 
allocation confidential, participants are requested prior 
to each assessment not to reveal allocation or therapy 
content to the evaluators.
The raw data resulting from the outcome assessment 
has the same structure for both interventions, making it 
impossible to tell the group assignment without being in 
possession of the documents containing links between 
participant’s identity and their code number.
MEthods: dAtA CollECtIon, MAnAgEMEnt And AnAlysIs
data collection and management
The monitor of the study (EL) is in charge of over-
seeing the progress of the RCT and ensuring that it is 
conducted, recorded and reported in accordance with 
the protocol, Good Clinical Practice (GCP) and regula-
tory requirements.
The monitor supplies case report forms (CRFs), which 
are filled in by the evaluator at each site. The evaluator 
is responsible to document all data obtained during the 
study, which is identified by participant code number. 
This also applies to data for patients who, after having 
consented to participate, undergo the baseline examina-
tions required for inclusion in the study, but who are not 
included. No items in the CRF are to be left unattended: 
if data are missing or are impossible to obtain, these 
should be documented as ‘not available’ (NA) and the 
reasons for missing data must be noted in the document.
All data are recorded and stored in digital form on 
encrypted electronic devices. Documents containing 
links between a participant’s identity and their code 
number exist only in paper form and are kept in locked 
file cabinets with limited access at the investigation site 
where the participants have been treated. In accordance 
with the regulations issued by The Swedish Data Protec-
tion Authority, a personal register will be established.
The clinical investigators are responsible to probe, via 
discussion with the participant, for the occurrence of 
adverse events during each visit and record the informa-
tion in the patient CRF. Adverse events must be described 
by duration (start and stop dates and times), severity, 
outcome, treatment and relation to study device, or if 
unrelated, the cause. The investigator must report any 
reportable event to the monitor in acceptable timely 
conditions, but not later than three working days after 
the occurrence of the event.
The sponsor must report to the Medical Products 
Agency (Läkemedelsverket) any serious adverse event, 
which indicates an imminent risk of death, serious injury 
or serious illness and that requires prompt remedial 
action for other patients, users or other persons immedi-
ately, but not later than two working days after becoming 
aware of a new reportable event or of new information in 
relation to an already reported event.
Once all the data are collected, checked and corrected, 
the database is closed, and analyses performed. All data 
transfer, processing and analyses are done using deper-
sonalised data, and all the data sets are protected by pass-
word. In order to promote data quality, the evaluators are 
trained on all the data collection and management proce-
dures and are provided with written instructions by the 
first (EL) and last (MO-C) authors.
To incentivise the completion of the follow-up, the 
patients are given the choice to participate in these assess-
ments at the clinic or via a phone interview with the eval-
uators. When possible, follow-up assessments are also 
conducted with participants that had discontinued the 
treatment or withdrew from the study.
statistical methods
The main analysis will be performed in terms of change 
from baseline to the measurement at treatment comple-
tion using the intention to treat (ITT) population, 
namely all the participants enrolled into the study consid-
ered according to their intial allocation. Complementary 
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analyses will be performed on the per-protocol (PP) 
population with respect to the change from baseline 
to the follow-up assessments at 1, 3 and 6 months after 
completion. These complementary analyses will include 
also the data coming from patients that, after appropriate 
washout period to exclude carry-over, have crossed over 
to the alternative treatment. Both the ITT population 
and the PP population will be specified in detail at the 
Clean file meeting before the database lock and before 
breaking the code. The PP population will be restricted 
to the participants who successfully complete all 15 treat-
ment sessions.
Suitable graphical and numerical summaries will be 
provided for all the variables measured and for corre-
sponding changes in scores.
For the main unadjusted comparison between two 
groups, Fisher’s non-parametric permutation test will be 
used for continuous variables, Mantel-Haenszel χ2 test 
for ordered categorical variables, Fisher’s exact test for 
dichotomous variables and Pearson’s χ2 test for non-or-
dered categorical variables. CIs at 95% for the mean 
differences between two groups will be given when appro-
priate. If differences exist between the two randomised 
groups between baseline variables that could influence 
the outcome variables, a complementary adjusted analysis 
will be performed for these baseline variables.
For adjusted comparison between two groups, anal-
ysis of covariance will be used for continuous outcome 
variables not obviously non-normally distributed with 
intervention/control as independent variable and all 
confounders as covariates.
For analysis of change within groups, Wilcoxon signed-
rank test will be used for continuous variables and sign 
test for ordered categorical and dichotomous variables. 
A complementary mixed model analysis between the two 
treatments regarding the primary efficacy variable with 
centre as random effect will be used to correct for the 
centre-effect in the statistical models.
All correlations will be performed with Spearman’s 
correlation coefficient. The distribution of continuous vari-
ables will be given as mean, SD, median, minimum and 
maximum, and distribution of categorical variables will be 
given as numbers and percentages. All statistical tests will be 
two sided and conducted at the 5% significance level. The 
theory of sequential multiple test procedures will be applied 
for the primary analysis and for secondary analyses. If a test 
gives a significant result at the 5% significance level, the 
total test mass will be transferred to the following number in 
the test sequence until a non-significant result is achieved. 
All these significant tests will be considered confirmative. A 
Statistical Analysis Plan will be written with all detailed statis-
tical analyses specified.
Patient and public involvement
The design of the study was informed by the experience 
with our previous clinical investigation,6 thanks to which 
patients’ priorities, experience and preferences were identi-
fied and used for the development of the research question 
and outcome measures of the current RCT. The burden 
of the control intervention was assessed with a pilot study 
on volunteers with past experience with the experimental 
intervention.
Ethics and dissemination
Research ethics approval
There are no known risks associated with the experimental 
or control treatments, and clinically significant deteriora-
tion is rare. Possible individual benefits include reduced 
PLP, reduced disability associated with pain and improve-
ment in various aspects related to quality of life. This trial 
has been approved by the governing ethical committees of 
each participating country. Important protocol modifica-
tions will be reported in a timely manner to all the relevant 
parties.
Access to data
The principal investigator, MO-C, has full access to all of the 
data in the study except the documents containing the link 
between patient’s identity and their code number, which 
will be accessible only after the completion of the data anal-
yses. MO-C takes responsibility for the integrity of the data 
and the accuracy of the data analysis.
Dissemination policy
Regardless of the significance, direction or magnitude 
of effect, the consortium will publish the findings of this 
study in scientific, peer-reviewed journals and conferences 
following the Consolidated Standards of Reporting Trials 
guidelines. All the clinical investigators will author the scien-
tific article reporting the results of the trial. Results will be 
also disseminated to all the participants of the study with a 
report. No professional writers external to the study will be 
used aside from conventional English proof reading. Access 
to the detailed clinical investigation plan, participant-level 
dataset and statistical code will be granted based on reason-
able requests after the publication of the study.
trial status
This clinical trial is currently in the participant enrolment 
phase. Fourteen patients have been randomised and are 
under treatment at November 2017. It is anticipated that 
full analysis will be finalised in April 2020.
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Purpose: Phantom motor execution (PME) facilitated by augmented/virtual reality (AR/
VR) and serious gaming (SG) has been proposed as a treatment for phantom limb pain
(PLP). Evidence of the efficacy of this approach was obtained through a clinical trial
involving individuals with chronic intractable PLP affecting the upper limb, and further
evidence is currently being sought with a multi-sited, international, double blind, rando-
mized, controlled clinical trial in upper and lower limb amputees. All experiments have been
conducted in a clinical setting supervised by a therapist. Here, we present a series of case
studies (two upper and two lower limb amputees) on the use of PME as a self-treatment. We
explore the benefits and the challenges encountered in translation from clinic to home use
with a holistic, mixed-methods approach, employing both quantitative and qualitative meth-
ods from engineering, medical anthropology, and user interface design.
Patients and Methods: All patients were provided with and trained to use a myoelectric
pattern recognition and AR/VR device for PME. Patients took these devices home and used
them independently over 12 months.
Results: We found that patients were capable of conducting PME as a self-treatment and
incorporated the device into their daily life routines. Use patterns and adherence to PME practice
were not only driven by the presence of PLP but also influenced by patients’ perceived need and
social context. The main barriers to therapy adherence were time and availability of single-use
electrodes, both of which could be resolved, or attenuated, by informed design considerations.
Conclusion: Our findings suggest that adherence to treatment, and thus related outcomes, could
be further improved by considering disparate user types and their utilization patterns. Our study
highlights the importance of understanding, from multiple disciplinary angles, the tight coupling
and interplay between pain, perceived need, and use of medical devices in patient-initiated therapy.
Keywords: phantom limb pain, neuropathic pain, augmented reality, phantom motor
execution, ethnography, user interaction design
Introduction
Phantom limb pain (PLP) has been defined by the International Association for the Study
of Pain (IASP) based on its perceived location; the phantom limb (IASP global year
against neuropathic pain (2014–2015)). However, phantom limb pain (hereafter referred
to as PLP) has a complex etiology and thus can be elicited by different sources, such as
nociceptive (neuromas) and/or neuropathic.1 Promising results have recently been
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published using surgical innervations to address nociceptive
sources (neuroma pain),2,3 but neuropathic causes remain
unresolved,4 even by pharmacological interventions.5 This
work is focused on neuropathic PLP and a non-invasive, non-
pharmacological method to treat it.
PLP has been hypothesized as arising from the stochas-
tic entanglement of the pain neurosignature with impaired
sensorimotor circuitry.1 In accordance with the implica-
tions of this hypothesis, a myoelectric pattern recognition
(MPR) device was developed to promote Phantom Motor
Execution (PME) as a treatment for PLP. PME engages
motor neural circuitry in the central and peripheral nervous
systems, ultimately resulting in the activation of the mus-
culature at the residual limb while attempting phantom
movements. By extracting motor intention from the
stump’s muscular activity, one can provide patients with
real-time feedback utilizing Augmented and Virtual
Reality (AR/VR), as well as serious gaming (SG).6
Preliminary evidence of the efficacy of this approach
was obtained through a clinical trial involving individuals
with intractable PLP affecting the upper limb,7 and further
evidence is currently being sought with a multi-sited, inter-
national, double blind, randomized, controlled clinical trial
with upper and lower limb amputees.8 All these experi-
ments have been conducted in a clinical setting supervised
by a therapist. However, when considering how the reduc-
tion of PLP relates to acquisition and maintenance of motor
skills of the phantom limb, the question naturally emerges
as to whether this treatment approach could be self-
administered at home. The learning of phantom motor skills
requires practice and occasional rehearsal is likely neces-
sary to maintain said skills. With this in mind, we deemed it
sensible to explore the feasibility of embedding PME in
patients’ home environments and daily life.
Studies of prescribed home use therapies have sug-
gested that approximately 65 percent of patients will be
non-adherent to some degree, due to factors such as life-
style changes, complexity of the prescribed regime, lack of
ability to fit the regime into normal routines, and the
patient’s internal level of motivation to do the treatment.9
We were interested in understanding how these extrinsic
lifestyle and personal factors interact with the patient’s
perceived need for the treatment as governed by pain
levels, producing particular patterns of use and adherence.
In this manuscript, we present a series of four case
studies on the use of Phantom Motor Execution as a self-
treatment strategy for PLP. These case reports, involving
two transhumeral and two transfemoral amputees, describe
these patient’s experiences using the therapy in their
homes. We aimed to explore the benefits and the transla-
tional challenges encountered in the transition from clinic
to home use. We hypothesized that home therapy yields
efficacious results in pain reduction comparable to findings
observed in the clinic, with the advantages of independent,
customizable, personalized use outside of the hospital, as
patients adapt the therapy to their individual preferences
and lifestyles. In developing a more holistic understanding
of how patients use the device at home and motivate
themselves to perform the therapy, design recommenda-
tions can be drawn for future development of at home-
based therapy systems.
In this study, we employ a multidisciplinary approach,
enlisting the methodical and analytical tools of
a biomedical engineer, medical anthropologist, and user
interface designer. We chose this approach to elucidate not
only the technical and quantitative data surrounding
patients’ in-home use of the therapy, but also to understand
qualitatively the patient’s relationship with their device
and therapy program and develop design requirements
for future in-home device development. Medical anthro-
pology is the study of how social, cultural, biological, and
structural factors intersect and interact with people’s
experiences of health, illness, medical treatments, and
differentially distributed access to well-being. The primary
methodological tool of anthropology is ethnography – sus-
tained, immersive, long-term exposure of the anthropolo-
gist to individual’s lives and worlds – in the endeavor to
get as close as possible to understanding their firsthand
experiences, practices, and values. Medical anthropology
thus has the potential to complement, deepen, and even
sometimes challenge the study of medical interventions
through a more holistic lens.
Our study engages ethnographic insights into the lives
of patients, involvement of family members, and beha-
vioral patterns surrounding therapy to contextualize the
clinical and quantitative perspectives. This multidisciplin-
ary approach allows us to identify patterns otherwise over-
looked using one method alone, offering an expanded
appreciation of the many interrelated variables (physical,
social, and structural) that drive patient home therapy
regimes. Our study thus offers a methodological example
of how engineers can work alongside interaction designers
and anthropologists to produce a more deeply situated
understanding of medical device development, use and
efficacy, with the final aim of bringing such a device into
the hands of the patient.
Lendaro et al Dovepress
submit your manuscript | www.dovepress.com
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Materials and Methods
Design
All patients were provided with and trained to use a MPR
and AR/VR device in a laboratory and/or clinical setting.
Patients then took these devices home and used them
freely and independently over the course of 12 months.
At the end of the treatment period, the research group
interviewed the subjects in an in-home setting and gath-
ered the training data stored by the training software. The
study was approved by the Regional Ethical Review Board
in Gothenburg and was carried out in accordance with the
relevant guidelines and regulations. All subjects provided
their written informed consent to take part in the study and
its publication.
Participants
Four limb loss patients (2 upper and 2 lower limb ampu-
tees) participated in this study. In the following we
describe their backgrounds and their introductions to
PME treatment.
Subject 1
Subject 1 (S1) is a 77-year-old man (born in 1941) who
underwent an acute transhumeral amputation over 50 years
ago (1964) in a motor vehicle accident, at age 24. S1
suffered from incapacitating phantom limb pain soon
after the amputation, which severely impacted his sleep,
mood, and ability to work. S1 experienced limited but
unsustained PLP relief from hypnosis and mirror therapy.
S1 was the first patient to undergo the PME treatment in
2013, resulting in the relief of nearly 50 years of PLP.6 S1
was also the first person to use the device in-home, outside
the clinic or laboratory.
Subject 2
Subject 2 (S2) is a 56-year-old man who lost his arm in 2011
in a tractor accident. He developed phantom limb pain
directly after the accident, which he described manifesting
as his hand clenched tightly in a fist. In 2014, he commenced
PME therapy joining the first clinical trial on PME.7 S2 had
consistently taken morphine since the accident to help man-
age his PLP. Before joining the clinical trial, he used to take
morphine pills in combination with morphine plasters, how-
ever by the end of his participation in the clinical trial he
abandoned the plasters. He noticed that the valence of his
pain changes with the seasons, getting markedly worse dur-
ing winter, and he is currently using oxynorm (5mg/daily) to
supplement his pain management.
Subject 3
Subject 3 (S3) is a 72-year old man who lost his leg in
1985 in a tractor accident. For the first 19 years after his
accident, he did not experience debilitating phantom limb
pain. Yet in 2014 S3 started to experience “unbearable”
pain. The patient subsequently took part in a study using
PME in lower extremities, which resulted in a significant
decrease in PLP.10 Following sustained PME treatment,
the patient reported that his pain has returned to the level
it was 20 years ago, “a manageable place.” S3’s pain was
reported as worst in the middle of the night, when nothing
else can distract him. As his son described, “my father is
incredibly active. When he is always moving his body, he
can’t feel the pain. He once told me he wished he could
just keep busy working for 24 hrs straight.”
Subject 4
Subject 4 (S4), at 28 years old, is the youngest and in-
home PME and AR/VR device user, and the only female
in this study. She is a transfemoral amputee who lost her
leg in a motor vehicle accident in 2009, when she was 18
years old. S4’s phantom limb pain began almost immedi-
ately after her amputation and was, as she describes,
“excruciating”. S4 was prescribed a heavy dosage of oxy-
codone to manage her pain. For nine years, she continued
taking oxycodone pills consistently. The pill was the only
thing that allowed her to sleep, to escape what she called
a “gnawing, annoying, relentless” sensation. She did not
pursue any other pain management treatments during this
time but was troubled by the strength of the medication
and its numbing effects. In 2017, S4 was trained in PME
and the AR/VR device in lab settings, upon which she
took the device home with her. She continued the treat-
ment at home, allowing periods of complete cessation of
oxycodone.
Intervention: Home Use System
The PME treatment facilitated by MPR, VR/AR, and SG
has been extensively described previously for the upper
limb6,7 and for the lower limb.10,11 The same treatment
methods were employed in this study. Briefly, motion
intent is inferred via MPR using myoelectric activity
from the stump musculature. First, the MPR algorithm is
trained by recording the myoelectric signals associated
with the phantom motions to be exercised. Once the
aimed motions are trained and thus recognized by the
decoder, these can be used to command the following
virtual environments:
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1. A VR environment featuring a virtual limb that is
freely controlled by the subject.
2. An AR environment to allow the subject to visua-
lize themselves (in real-time) with a virtual arm/leg
superimposed on their stump. The AR environment
uses a conventional webcam which inputs a video
feed that is analysed to track a fiducial marker, thus
allowing the virtual limb to remain in the anatomi-
cally correct position while the subject moves.
3. A racing game (Trackmania Nations Forever, free
version) controlled by the subject’s limb movements.
4. Target Achievement Control (TAC) test initially
introduced by Simon and colleagues12 and used in
this study as implemented in BioPatRec.13 The test
requires the subject to match target postures pre-
sented in random order on the screen. The subject
attempts to match the posture by moving the virtual
limb with accuracy (i.e. the target posture can be
overshot) and within a 10-second interval.
A user-friendly system (software and hardware) was
developed for independent use at home. The software
included a pain survey to monitor the level of PLP based
on the Short Form of the McGill Pain Questionnaire (SF-
MPQ) since prior clinical evidence gathered from patients
using our system indicated this metric as the most sensi-
tive measure of changes in pain.7 Although subjects in this
study were free to use the system according to their needs
and to best suit their lifestyles and schedules, the recom-
mended regimen was two sessions per week for at least
90 mins of training (this regimen has demonstrated effica-
cious in our previous clinical experience). Patients were
also asked to occasionally fill in the pain survey in order to
monitor the long-term profile of their PLP.
Data Collection and Outcome Measures
Data concerning the use of the system was stored in the soft-
ware and collected at the end of the one-year study period. We
monitored the frequency of the sessions, number of recording
session per session and number and type of motions per
recording session. Data regarding pain was collected through
the self-administered questionnaire included in the software,
which reports dates and times. The subjects were instructed to
fill in the questionnaire at the end of every training session.
The outcome measures considered were:
● Treatment adherence: Monitored as the number of
sessions carried out monthly.
● Session duration: Inferred from the timestamps of the
recording sessions as the time elapsed between the
first and last recording of the day. This time interval
was then increased by the average time between two
consecutive recording sessions in order to account for
the time spent in virtual environments by training
with the last recording session.
● Pain Rating Index: Computed as the sum of the
scores for all descriptors of the Short Form of the
McGill Pain Questionnaire (SF-MPQ).14 The SF-
MPQ consists of 15 pain descriptors rated on
a 4-point scale from 0 to 3. The range of the PRI is
therefore 0 to 45.
Due to the small sample size and variations in patients’
home situations, lifestyles and personal preferences, this
study was not conducted as a clinical trial, nor does it draw
conclusions of statistical significance. Rather, it is a series
of case studies following patient progress through the
therapeutic regimen.
Ethnographic Methods
In-depth, unstructured and non-directive interviews15 lasting
from 60–90 mins were conducted with each patient in their
home environments. The interviews were aimed at elucidating
patient narratives,16,17 medical history, prior experience with
phantom limb pain and treatment therapies, and the broader
holistic context of the person’s life, family, hobbies, motiva-
tions, and personality. Yet acknowledging that people do not
always readily articulate their behaviors and practices when
asked about them, these interviews were complemented by
participant observation18 during rehabilitation. Employing
a patient-centred approach to ethnography,19 which empha-
sizes intimate attention to an individual’s subjective and emic
“experience-near,” the anthropologist followed subjects in
their homes, chronicling their strategies for navigating every-
day life with their devices. These engagements reach beyond
what subjects say in self-report into the realm of embodied
practice.
Survey of Use Preference
A self-report questionnaire was administered to identify how
long the subjects used each training exercise as well as
whether they preferred a certain type over the other. In addi-
tion, the subjects were asked in an open-ended question for
feedback about possible improvements of the system for
home use. The results from the self-report survey were incor-
porated with the ethnographic data using the KJ Method to
Lendaro et al Dovepress
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develop insight into the themes and relationships among the
qualitative data20. The basic steps of the KJ Method are as
follows. First, quotes are extracted from a qualitative data
source, such as interviews or surveys, and written down on
separate cards. The quotes are then scanned to identify com-
mon themes, and subsequently grouped together under the
headings of these themes. These classifications are inherently
subjective and decided upon by the researcher(s)’ interpreta-
tion of the data. Further naming and subclassification of the
assorted groups is then performed as needed. This classified
data from the KJ Method was used to identify user types and
suggest future requirements from the therapy regime.
Results
Usage data for the four participants were gathered over
one year of study and are summarized in bar graphs showing
adherence to the treatment, and in histograms showing the
distribution of session durations. Self-reported pain levels
over time are illustrated as trends of Pain Rating Index (PRI)
over time. All the data are summarized per subject and
illustrated in Figure 1–4 (one figure per subject), which
consists of three panels (A–C). The results of the survey
about use preferences are reported in Table 1.
Panel (A) of Figure 1–4 reports the trend of the self-
reported level of pain as estimated by the PRI (range
0–45), presented as monthly average. The typical pain
descriptors chosen by each subject are reported in the
respective captions: as it can be noted from all figures,
the level of pain remained relatively constant and low over
time. Consequently, the pain descriptors also held stable,
showing mild variations only within the individual ratings.
Each of the adherence bar plots (panel (B) in Figure 1–4)
condense information about therapy adherence as percentage
of the suggested monthly sessions carried out by each partici-
pant. Biweekly training (eight sessions per month) was con-
sidered the optimal treatment frequency. For example, the first
bar of Figure 1B shows a treatment adherence of 137.5%,
meaning that Subject 1 carried out 11 training sessions during
the first month. Note that the subjects started the home treat-
ment in different months; it ensues that “month 1“ in the x-axis
does not correspond to a specific month but rather the start of
the treatment for that specific subject. The number on top of
each bar represents the average number of movements per
recording session month by month. The training software
theoretically allows the user to train up to 18 movements
simultaneously. However, patients can rarely achieve above
six movements due partly to the limitations posed by MPR
with surface EMG and a limited number of recording channels
(up to eight, in the device used).Reporting themonthly average
of movements performed per recording session is taken to
Figure 1 Panel (A) presents the self-reported level of pain as expressed by the Pain Rating Index (the sum of the scores give to the chosen McGill pain descriptors) over
time (x-axis). The range of the PRI is between 0 and 45 however the range of y-axis of this graph has been reduced to 0–15 to improve the quality of the data visualization,
since this is the interval containing the PRI for all participants. The value presented in the graph is the monthly average (y-axis). Pain level was not reported in those months
where no data points are shown. (B) Treatment adherence data expressed as percentage of the suggested treatment frequency (eight sessions a month). The number
presented on top of each bar represents the average number of movements trained in a given month. (C) Histogram of the session duration, each bar represents the
number of session (value on the y-axis) of a given length (value on the x-axis). Figure 1 presents data relative to Subject 1. The only pain descriptor reported by Subject 1 is
hot-burning.
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indicate the complexity of the exercises carried out: the more
movements trained within the same recording session, the
higher the complexity of the classification task for the MPR
algorithm. An increasing number of movements requires
superior motor skills of the stump musculature in order to
maintain quality performance with the VR/AR and SG
environments.
From this way of presenting adherence data, it becomes
clear that over the course of the first seven months the usage
frequency generally decreases among all subjects. Subject 1
starts in January and interrupts the treatment between July
and September, resuming the therapy with 100% adherence
in October. S2 starts in August but phases out completely by
March. S3 starts in December and trains throughout the
Figure 2 Data relative to Subject 2 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 2 were: throbbing, shooting, stabbing and aching.
Figure 3 Data relative to Subject 3 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 3 were: throbbing, stabbing, sharp, gnawing, hot-burning, aching and splitting.
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whole year: the frequency of training decreases in over
summer months only to increase again during the following
winter. S4 starts in October and trains with decreasing fre-
quency over the following 7 months; after a long interruption
of four months, she returns to therapy at the end of the
monitoring year.
The complexity of the movements appears idiosyncratic;
for each subject such idiosyncracy remains relatively con-
stant over time. Session duration, in panel C, is presented in
the form of histograms and indicates that all subjects spent
less time training than the advised 90 mins, but also shows
a large within-subject variation of session length.
Figure 4 Data relative to Subject 4 presented in an analogous way to Figure 1. Panel (A) presents the self-reported level of pain; (B) treatment adherence; (C) histogram of
the session duration. Typical pain descriptors reported by Subject 4 were: cramping, gnawing, heavy, tender, tiring-exhausting, punishing-cruel.
Table 1 Self-Reported Use Preferences Using PME Device
Self-Reported Use Preferences S1 S3 S4
Therapy Duration 1.5 hrs-2 hrs 1 hr-1.5 hrs 1.5 hrs-2 hrs
Average TAC Time 0–10 mins More than 20 mins 15–20 mins
Average AR Time More than 20 mins More than 20 mins 0–10 mins
Average VR Time I do not use the VR Limb More than 20 mins 0–10 mins
Average Game Time 0–10 mins I do not use the race car game I do not use the race car game
Preferred Exercise AR Limb TAC Test TAC Test
Factors that Prevent you from doing
therapy
Time Shortage Number of Electrodes Time Shortage
What additional assistance do you
need to carry out the session
None Not needed, practiced many times
and learned by doing
Someone who feels where to place
the electrodes on the muscles
Progress Marker Increase in Sleep, decrease
in daily pain levels
Pain decreases by 30–50% -
Open Recommendations - Reusable Electrode interface, shorter
treatment times more often
More exercises with a goal to reach,
and reduce timing
Abbreviations: PLP, phantom limb pain; MPR, myoelectric pattern recognition; PME, phantom motor execution; AR/VR, Augmented and Virtual Reality; SG, serious gaming;
TAC, Target Achievement Control; SF-MPQ, Short Form of the McGill Pain Questionnaire; PRI, pain rating index; PMI, Phantom Motor Imagery.
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Table 1 displays the results of the user preference
survey. It was not possible to survey S2 because he termi-
nated the use of the device several months preceding the
interview time. From these results a discrepancy emerges
in the estimate of time spent training as inferred from the
data stored in the software (panel C of Figure 1–4) versus
the data reported by the users themselves (Table 1), with
the latter always exceeding the former.
Ethnographic Results
Ethnographic results are first presented for each subject,
followed by ethnographic analysis of cross-cutting themes
among all subjects, elucidating four key findings. All
descriptors regarding the therapy and pain experiences
that are contained in quotations are subjects’ own words
from interviews with the anthropologist. These descriptors
were chosen by the subjects themselves, elicited through
their own free-associations, rather than offered as prompts
in the interview. Descriptors regarding therapy and pain
experience that are not contained in quotations are the
anthropologists’ observations and interpretations drawn
from participant observation as well as themes present in
the interviews.
S1 reported a shift in frequency and consistency of his at-
home treatment, largely depending on his level of present
pain and corresponding motivation. For the first few years
using PME at-home, S1 practiced the therapy regularly:
It was much simpler for me to use the system at home.
I started with ambition. If I did it every day, what would
happen? For a time I used it every other day, just to see if
the pain were to disappear even more, but there actually
wasn’t too much of a difference.
After a few months of frequent sessions at home, S1 was
able to stabilize his pain levels with less regular intervals
of the therapy. When pain was manageable, S1 deprior-
itized the therapy. “I wish I did it a bit more often,” S1
admitted. “I’m not hindering you!” S1’s wife chimed in.
S1 acknowledged that his wife often reminds him to prac-
tice the therapy, citing that she can “sense a difference”
when he has been more regular with the treatment. Still,
“life gets in the way,” as he explained, and sometimes
weeks pass between his treatment sessions:
It’s easy to say ‘no, I have to do this first.’ So that is the
problem when one is responsible at home for their own
treatment. One must prioritize the treatment. When I start
to feel that the pain is becoming a problem again, then
I prioritize it. When the pain isn’t so bad, I think ‘not just
now, I can do it tomorrow.
Here, S1 highlighted the challenge of in-home treatment
maintenance when pain is not so present or acute and that
the use of the therapy is often driven by current pain level.
S1 reported that he typically performs a treatment session
for two hours. Despite years of using the AR/VR device, S1
continued to find enjoyment and novelty in the treatment.
“It doesn’t feel like (two hours) because it takes so much
concentration, it’s so fun even after all these years . . . it’s
not very easy, it requires concentration, it isn’t the same
every time,” he reflected. S1 progressed through all four
activities but tends to prefer the AR configuration and the
TAC test. A former professional race car driver, S1 enjoyed
playing the game, especially delighting when he can steer
the car with movements from his little finger, motivated by
reaching a “best time.” Despite his familiarity with the
device, some elements, including electrode placement on
the skin of the residual limb to record clear myoelectric
signals, remained “challenging” throughout the course of
the study. From time to time signal quality still varies. One
time I got such good signals that I took a permanent pen
and marked on my skin where they were. But it washed
away after a few showers. This one is easy, he points to one
electrode that lay just above a scar, “I just follow the scar
slightly up.” As S1’s description demonstrates, in-home use
of the AR/VR device requires learning and knowing the
locations on one’s body in relation to signal quality. During
one treatment session, the anthropologist noticed S1
whispering under his breath, intently focused on the virtual
on-screen hand, coaxing the little finger as if he were
addressing a young child. This moment evinced the degree
to which patients like S1 envision the virtual arm as inti-
mately connected to the user’s own body – if not a virtual
representation of one’s own phantom hand, then at least
something which they can guide and control with effort and
positive self-talk. “The best part is when I can control these
little fingers here,” he points to the fourth and fifth fingers.
“That happens just a few days a year. It happened just three
nights ago!” This challenge—seeing if he can control the
two little fingers—seemed to drive each and every treatment
session, his barometer of success. “The brain realizes that
one can move the little fingers; it realizes they (still) exist
there,” he explained. His invocation of the brain speaks,
uncannily, to the underlying theory of PME.
S2 is a unique patient in that he adapted PME therapy
to not require the use of the AR/VR device, a regimen he
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calls “in-head exercises.” S2 ceased the use of the device
because he felt only a few minutes of training was neces-
sary to achieve pain relief, and this was not worth the time
required to place the electrodes. When the research team
visited S2 at his home, they were most interested in better
understanding how he practices PME without the AR/VR
device. It was crucial to ensure S2 was not merely envi-
sioning or imagining the movements in his mind (which
would purportedly only engage Phantom Motor Imagery
[PMI]) but rather that he was actively engaging the muscle
groups around the stump to execute movement in the
phantom arm and hand (purportedly engaging the sensor-
imotor system). S2 described his method as such: He sits
or lays on the sofa and tries to relax, directing his attention
to the phantom pain (which he otherwise tries to avoid it
through distraction). He first thinks about the movement,
then performs the movement, feeling the muscles in his
residual limb contract. In this description, S2 made a clear
distinction between passively thinking and actively per-
forming the movement, signaling to the research team that
he was in fact engaging the muscles in the way PME
intends. Like the other three subjects, S2 developed his
own routine for practicing PME, yet his was more frequent
with a much shorter duration: he trained roughly four
times a day, for just one to two minutes at a time. The
exercise he most often performed was opening and closing
his phantom hand. It took only one minute before he
started to feel the pain diminish. Still, S2 continued to
take oxycodone to manage his pain every day. However,
he has greatly decreased his intake of pain medications,
halting his earlier use of morphine plasters and using low-
dose tablets instead. Still, it appeared that PME exercises
served as a supplement, while morphine remained his first-
line treatment. Interestingly, even though they did not
currently have an AR/VR device at home, S2 and his
wife took meticulous care of its operating instructions,
which they kept in a binder with pages laminated. In this
binder, they had pictures of S2’s stump with the electrodes
placed in their optimal position for producing the clearest
signals (his physiotherapist’s idea). Even despite his cur-
rent non-use of AR/VR device, S2 acknowledged its
importance in initiating his own treatment practice.
“Without the device, I would have never come up with
this method,” S2 said, referring to his “in-head exercises.”
S2’s case testifies to the possible efficacy of PME inde-
pendent of the therapeutic technology developed and tra-
ditionally used to facilitate it.
S3 was the subject who most enlists his family’s help
in the therapy’s practice. His wife participated actively in
each session, helping him set up the device, place the
electrodes on his stump, and navigate the program’s var-
ious activities on the laptop. His son was often involved as
well, troubleshooting when the program has any technical
difficulties, and was also the main point of contact
between S3 and the researchers. S3 also created the most
strictly regimented schedule for his PME treatments, built
into his family’s weekly routine: every Monday and
Thursday, around 5 or 6pm, before dinner. Each training
session, S3 began with a different leg movement. After
completing the recording session, he skipped the Virtual
Reality portion of the treatment, often preferring the
Augmented Reality version. In fact, he spent a majority
his time with AR/VR device using the Augmented Reality;
he disliked the car racing game as he found it tedious and
difficult to control (“I just kept crashing the car”). S3’s
son, who was actively involved in the treatment, encour-
aged his father to use the TAC test, reasoning that “it’s
better because there’s something to follow . . . so you know
what you’re doing,” but S3 seemed to prefer using the
Augmented Reality for its videocam representation of
himself, the room, and his virtual leg. The anthropologist
visited S3 twice – first with the research team and then
alone – and found that the patient responded positively to
the research team’s suggestions and advice with regards to
adherence and motivation. On the first visit, the patient
seemed to be struggling with the treatment and unabated
pain. A researcher identified S3 failed to follow the treat-
ment instructions. S3 had not been increasing the level of
challenge by performing new movements. The researcher
then stressed the importance of this progression for the
efficacy of the therapy. On the follow-up visit, the anthro-
pologist observed a marked behavioral, even emotional
shift in the patient’s interaction with the technology. S3’s
stamina and tolerance appeared much higher, he grew less
frustrated with the system, and the overall sense of moti-
vation, enjoyment, even “belief” (his own descriptor) in
the therapy, seemed much higher by the end of the study.
Concomitantly, the patient reported a “reduction” in his
phantom pain in the weeks following the implementation
of a refocused approach, as per the research team’s advice.
Of all in-home patients, it seemed that S3 and his family
had folded the AR/VR device into their home environment
in the most intimate way, with specific household arrange-
ments that facilitated the technology’s use. Unlike the
other patients, who used their laptop screen for the
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treatment, S3 broadcasted the AR/VR exercises from his
laptop onto a large TV screen in the living room. His wife
and he purchased the laptop specifically for using the PME
software. They stored the laptop and device on a roller-
cart, which they covered with a towel, the same towel that
S3 later placed on top of a chair to sit on when he per-
forms the treatment. S3 and his wife have appropriated
other everyday home objects into helpful tools that
enabled the use of the AR/VR device. Since the reference
electrode placed on S3’s wrist often slipped due to sweat,
they regularly placed a rubber band around it. S3 and his
wife pasted the AR-reference, a barcode-looking piece of
paper used to track the virtual arm onto the webcam of the
patient’s body, onto the cover of an old hardcover book,
which they placed at the foot of S3’s chair when not in
use. S3’s wife also recorded S3’s activity scores in
a handwritten notebook, actively participating in her hus-
band’s treatment. This manual progress-tracking consti-
tuted a form of care and sociality formed around the
therapy.
S4 began her in-home PME treatment on the sugges-
tion of a friend who was familiar with the treatment. She
began to notice that it was “working” (her term) when one
night, two months after she started the treatment and for
the first time in nine years, she forgot to take her oxyco-
done pill. To her surprise, she slept an entire night without
pain. She then continued ceasing her pills for one month
but kept practicing PME. Several weeks later, she also
stopped her PME treatment, thinking “it had worked”
and was no longer necessary. But one month later, the
PLP and disrupted sleep returned. This initiated a period
of titrating between oxycodone and PME. S4 took the pill
on and off, and began training with AR/VR device again,
just twice a month. Five months after initiating the in-
home treatment, she had continued this titration process,
moving between sporadic oxycodone use and sporadic
PME training to regulate her pain. S4 found that when
she is not taking oxycodone, she was “more awake, ener-
getic, less groggy,” and had more responsive reflexes. At
the beginning of her treatment, S4’s at-home PME ses-
sions would last 1.5–2 hrs. After several treatments, she
reduced their duration to 1–1.5 hrs. While at the outset she
utilized all of the AR/VR device activities (VR, AR, TAC
Test, and gaming), she preferred to use the TAC Test,
finding it “most helpful and effective” and began focusing
her time and energy solely on that activity. At the time of
the interview, her PME regimen consisted of a recording
session for multiple simultaneous movements and two to
three rounds of the TAC Test, which takes her roughly 1 to
1.5 hrs. For S4, a decrease (or cessation) of oxycodone
signified the efficacy of PME as a stand-in treatment. Her
assessment of whether the treatment was “working” chan-
ged over the course of the study in proportion to her use of
it (more consistent use correlated to greater perceived
efficacy). Her approach to focusing on the TAC Test also
evinced an optimization of the treatment to fit her needs,
a personalization of the therapy. S4’s affinity with the TAC
Test spoke to her broader identity as a professional athlete,
motivated by the pursuit of scoring points and reaching
goals. As S4 explained, “The TAC Test is an exercise
where you have to reach the goal.” She described this
goal-reaching aspect as motivating; a higher score yields
greater satisfaction. After several months of using the AR/
VR device, she expressed that she had identified how to
reach a higher score: she must optimize the electrode
placement positioning on her stump. S4’s goal score for
each treatment session was 100%; she repeated the test
until she reached as close as possible and attempted to
repeat this two or three times. As such, her treatment
session was guided less by a specific set time length, or
by the progression through the PME exercises, but by the
achievement of her self-identified “goal” (100% on the
TAC Test). S4 found the AR/VR device itself a bit cum-
bersome; the software was not compatible with her Mac
laptop, so she had to borrow her grandmother’s PC laptop.
S4 learned to place the electrodes on her stump herself but
enlisted the help of friends in their placement, as well as
over Skype with the research team in Gothenburg.
The analysis of ethnographic research elucidated the
following four key findings:
1. Subjects developed their own PME routines sur-
rounding frequency of practice and which activities
they prioritize (and deprioritize). These routines
varied from several-minute micro-sessions practiced
four times daily (S2), to regularly scheduled bi-
weekly evening sessions (S3), to more sporadic ad-
hoc use based on severity of pain and perceived
“need” for the treatment (S1 and S4). Subjects
worked the treatment into the contexts of their
everyday lives and saw the value of being able to
practice the therapy on their own time without hav-
ing to travel to the clinic. At the same time, some-
times life “gets in the way” (S1) and postponing or
skipping treatment sessions became easier when
competing with the demands of everyday life.
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When this disruption occured, returning or increas-
ing pain signaled to those without a regular PME
schedule the need to re-prioritize their treatment.
2. Subjects customized and personalized PME to fit
their bodies, pain levels, personalities, interests,
and lifestyles. In doing so, they cultivated ways to
stay motivated and engaged in the therapy. Patients
personalized by prioritizing the AR/VR device
activities that best align with their needs. S1 per-
formed all activities sequentially, emphasizing the
AR configuration and gaming, gauging his perfor-
mance by his ability to move the fourth and little
fingers of his phantom hand independently. S2 per-
formed PME independent of the AR/VR device,
thus proving the potential viability of the therapy
absent of the device and its activities. S3 focused
almost exclusively on the AR configuration, which
he enjoyed most for its real-world reflection of his
home environment, but also performed the TAC
Test on the encouragement of his son, who believed
it was more goal-oriented and thus motivating. S4
prioritized the TAC Test for its feedback of
a percentage-based score; the pursuit of 100%
tapped into her athletic goal-oriented motivation.
3. For most subjects, PME fit within the wider context
of a pain management regimen. For three out of the
four subjects, it was a supplemental treatment used
in the context of continued low-dose pain medica-
tions, abating the need for higher dosage. While S1
had completely ceased use of pain medication since
using PME, S2 and S3 still took low-dose pain
meds daily. For these subjects, PME was
a supplemental treatment that allowed them to man-
age their pain on a lower dose. S4 vacillated
between taking pain meds and using PME, but
unlike S2 and S3, she alternated these treatments
rather than using them concomitantly.
4. In-home, the device became “domesticated” materi-
ally, contextually, and socially. Subjects like S3
recruited and adapted everyday home objects
(books, roller carts, rubber bands etc.) into supple-
mental objects in the use of the AR/VR device,
folding in the device into the material context of
the home. In this way, it can be said that the device
took up residence in subjects’ households. Family
members (in the case of S1 and S3) participated in
the treatment – actively, in the case of S3, whose
wife navigated the software interface and placed the
electrodes on her husband’s limb, and passively, in
the case of S1, whose wife reminded and encour-
aged him to practice the therapy regularly. Thus, it
was not only the subject, but also family members
who engaged with the device both directly and
indirectly.
Identification of User Types
The information regarding the use of the system was
extracted from the ethnographic unstructured interviews
and analyzed using the KJ methodology: Figure 5 sum-
marizes the resulting workflow.
Proceeding subject by subject, the anthropologist read
aloud relevant sections of the unstructured interview refer-
ring to the use of the system. The user researcher wrote
down quotes and paraphrased information on separate
cards. After reviewing each subject interview, the user
researcher then organized the cards according to the
themes that emerged: Personalized Dosing, Assistance/
Support System, Definition of Progress, Motivation,
Faith in Therapy, Storage of Device, Patient
Improvisation, Electrode Placement and Tracking
Progress. After studying these nine themes, the user
researcher and anthropologist searched for discrepancies
in themes within the groups to create further subgroups.
The categories with notable discrepancies in themes
included subjects’ approaches to personal dosing, their
definition of progress, their faith in therapy and their
motivations for performing the therapy. The data under
these categories was then subdivided into the two user
types: the goal-oriented user and the experiential user.
For the remaining five categories, no subcategorization
was needed.
These user types are archetypes, informed by but not
directly reflecting any one individual patient, used solely
to contextualize the functional requirements for the design
of the user interface. In some cases, patients straddled the
two user types. The survey results support these two user
types and also demonstrate differences in the time patients
spend on each AR/VR activity.
User Type I: Goal Oriented User
These users mark their progress with PME based on com-
pletion of a goal, rather than cumulative time passed, and
prefer goal-oriented activities such as the TAC test over
time-based activities like AR or VR. These users could be
more interested in feedback from the therapy in terms of
markers for completion of certain goals. S3 and S4 both
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exhibit patterns of a goal-oriented user in that they both
exhibit a preference to the TAC Test (see Table 1), in
which the user strives to achieve a goal movement.
While S3 identifies the TAC test as a preference, he also
practices often with the AR limb, which also corresponds
to User Type II patterns, indicating that user preferences
are not always clear-cut between the two types.
User Type II: Experiential User
These users see the therapy regime through the scope of
the AR experience, which renders the user’s physical body
and the virtual limb in the same screen using a webcam,
also reflecting their actual environment. The Experiential
User may place more importance on the realistic qualities
of the AR limb in terms of sizing, colour and shape as well
as how responsive and realistic the virtual limb is with
regards to the user’s perception of their phantom limb.
This user will often base their practice more on a time
marker than achieving a specific movement goal. This
pattern of use was ascertained in observation of S3’s pre-
ference for experiential practice through motor execution
and S1s self- preference (see Table 1). It must be noted
that patients may enter PME with previous experience
from other forms of pain management therapies, including
mirror therapy,21–23 where visual feedback is considered
the main conducive of pain relief: In these cases, the
verisimilitude of the anthropomorphic feedback is of
paramount importance. This introduces a potential discre-
pancy between the goal of PME therapy, which is based on
the improvement of the motor execution, and the user’s
expectations and goals. This may translate into
a preference for the anthropomorphic components of the
PME therapy, such as the AR, disfavoring those compo-
nents that do not involve a virtual limb, i.e. the racing
game. Furthermore, mirror therapy sessions may be based
off of practicing for a set amount of time rather than
reaching a motor execution goal. In order to address this
potential user bias and translate it into the new underlying
theory of PME, a time-aware software interface should be
developed in order to deliver feedback on the time spent at
each level of movement difficulty (single degree of free-
dom movements, multiple degree of freedom movements,
simultaneous movements) and motivate the patient to
attempt more complex movements or to test their skills
after the experiential practice.
Discussion
This study demonstrates the adaptability of a technological
therapy (PME) to treat PLP in the home, where patients
drive its usage. Hypotheses on the working mechanism of
PME as a treatment of PLP, as well as for the genesis of
the condition itself, have been discussed at length by
Ortiz-Catalan along with clinical results and potential con-
founding factors.1 The purpose of this study was not to
Figure 5 Flowchart presenting the steps and the results of the KJ analysis.
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assess therapeutic efficacy but rather to interpret how
a previously clinical therapy can be translated into home
contexts, at the user’s discretion. Subjects were instructed
to use the AR/VR device at will, adapting it to their needs.
The adherence data indicates that patients use the system
more intensively in the first weeks of receiving the device,
and then diminish their usage as pain decreases, as evi-
denced by lapses in use. Use is taken up again in an ad-hoc
fashion, at need, often driven by the recurrence of pain. As
a consequence, the pain graph might not necessarily depict
how the treatment affects patients’ pain, but rather how
their pain level drives the use of the therapy. Treatment
adherence, then, changes depending on patients’ needs.
This tight coupling and interplay between pain, per-
ceived need, and use requires a multidisciplinary
approach. Alone, the pain rating does not reflect every-
thing about the intricacies and motivations driving (or
deterring) a patient’s in-home device use. Therefore, we
involved an anthropologist and user interface designer,
along with their qualitative methodologies, to better under-
stand use behaviors, patterns, and barriers. Their analysis
indicates that users’ profiles differ depending not only
upon their needs, but also upon their motivations and
daily life contexts. Patient adherence is especially impor-
tant in this form of therapy because of the underlying
mechanisms of PME.1 This makes understanding and
designing for different user groups and understanding
user expectations a critical task to improving the adher-
ence and outcome of the therapy regime at home.
The self-reported use preferences indicate two key bar-
riers to adherence. The first is time. The therapy demands
significant time (one to two hours per session), requiring the
patient to incorporate the regimen into their everyday life.
The second barrier is the need for reusable electrodes. The
cost and availability of single-use electrodes can make the
therapy prohibitively expensive or inaccessible and therefore
could decrease adherence to therapy regime.
In order to design a device compatible with multiple
user types, the following functions are recommended. For
the Experiential User, a time display recording both dura-
tion and frequency will allow for tracking and recording
within the interface. AR should be further developed to
meet variations in skin color, nail color and size of limb, to
expand relevance to wider, more diverse user populations
and enhance their engagement. For the Goal Oriented
User, feedback on results (i.e. movement accuracy mea-
sured by the TAC test, level of complexity of limb move-
ment combinations) should be displayed to drive
motivation. Additional goal-oriented activities and mar-
kers could recognize accuracy on different combination
of movements. Indeed, the average number of limb move-
ments shown in panel B of Figure 1–4 does not evidence
any significant increase over time, indicating a need for the
software to prompt the patients to increase difficulty.
Users should be enabled to set personal goals for the
therapy using different measures of success (i.e. Increase
Movement Accuracy, Decrease Pain, Improve Sleep
Quality). User data (adherence, TAC scores, time) should
be comprehensively presented as a form of feedback and
self-monitoring. This underscores the need for ways to
track long-term progress, considering breaks in therapy
and consequent need to refresh PME skills. Finally, feed-
back on progression and level of complexity of move-
ments needed in therapy will make treatment sessions
more efficient.
The main limitations of this study include a small
sample size (n=4). The inherent variability of patients’
home situations makes generalizability difficult, but also
serves to demonstrate the versatility and flexibility of both
the device and its therapeutic applications. Patients have
adapted the regimen to their home lives and developed
personalized routines. This paper is a proof of concept.
Future research should focus on a more systematic and
robust investigation on the home use of the device, includ-
ing compliance over a longer period of time.
Conclusion
This study holds methodological relevance for a broader
research context beyond that of phantom limb pain.
Healthcare services and therapeutic technologies are
increasingly moving outside of the clinic into the home,
a global trend growing with the digitization and develop-
ment of artificial intelligence and user-friendly design.
This domestication of health technology raises both new
possibilities and challenges, as well as creates unprece-
dented encounters between humans and technologies in
their own domain, demanding a new approach to studying
these relations. This paper offers an example of how to
study and monitor the use of such health technologies in
the home. By including the social expertise of a medical
anthropologist and the human-machine interface expertise
of a user interface designer, we approach this phenomenon
holistically adding a social perspective to a question that
would normally be answered in terms of clinical and
quantitative data. What emerges is a more nuanced picture
of the motivations, barriers, and desires driving patient-led
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in-home care, which in turns is used to design interven-
tions that increase the technology’s capacity and relevance.
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